Les liens directs vers les publications et les recherches bibliographiques sont identifiés séparément. Aucun PMID ou DOI n'est inventé pour les 0 références en attente de correspondance. Vérifier un lien ne valide pas l'interprétation clinique. Détails de la méthode.

  1. US Food and Drug Administration. Guidance for Industry: Policy Regarding N-acetyl-L-cysteine. https://www.fda.gov/regulatory-information/search-fda-guidance-documents/guidance-industry-policy-regarding-n-acetyl-l-cysteine US Food and Drug Administration

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  2. NIH Office of Dietary Supplements. Omega-3 Fatty Acids: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Omega3FattyAcids-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  3. Baur JA, Sinclair DA. (2006). Therapeutic potential of resveratrol: the in vivo evidence. Nature Reviews Drug Discovery, 5(6), 493–506. PubMed · PMID 16732220
    DOI : 10.1038/nrd2060

    Contenus utilisant cette ressource : resvératrol

  4. Deijen JB, Orlebeke JF. (1994). Effect of tyrosine on cognitive function and blood pressure under stress. Brain Research Bulletin, 33(3), 319–323. PubMed · PMID 8293316
    DOI : 10.1016/0361-9230(94)90200-3

    Contenus utilisant cette ressource : L-Tyrosine Performance cérébrale des sportifs : preuves et limites des compléments

  5. Zangara A (2003). The psychopharmacology of huperzine A: an alkaloid with cognitive enhancing and neuroprotective properties of interest in the treatment of Alzheimer's disease. Pharmacology Biochemistry and Behavior, 75(3), 675–686. PubMed · PMID 12895686
    DOI: 10.1016/s0091-3057(03)00111-4

    Contenus utilisant cette ressource : Huperzine A

  6. Waegemans, T. et al. (2002). Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. Dementia and Geriatric Cognitive Disorders, 13(4), 217–224. PubMed · PMID 12006732
    DOI : 10.1159/000057700

    Contenus utilisant cette ressource : Piracétam

  7. Llewellyn DJ, et al. (2010). Vitamin D and risk of cognitive decline in elderly persons. Archives of Internal Medicine, 170(13), 1135–1141. PubMed · PMID 20625021
    DOI : 10.1001/archinternmed.2010.173

    Contenus utilisant cette ressource : Vitamine D3

  8. Therapeutic Goods Administration. (2026). Withania somnifera (Ashwagandha) and very rare risk of liver injury. https://www.tga.gov.au/news/safety-updates/withania-somnifera-ashwagandha-and-very-rare-risk-liver-injury Therapeutic Goods Administration

    Contenus utilisant cette ressource : Stress et cortisol : mesures humaines et recherche sur les compléments

  9. Bhagavan, H.N., Chopra, R.K. (2006). Coenzyme Q10: absorption, tissue uptake, metabolism and pharmacokinetics. Free Radical Research, 40(5), 445–453. PubMed · PMID 16551570
    DOI : 10.1080/10715760600617843

    Contenus utilisant cette ressource : Coenzyme Q10

  10. Eyles DW, et al. (2013). Vitamin D effects on brain development, adult brain function and the links between low levels of vitamin D and neuropsychiatric disease. Frontiers in Neuroendocrinology, 34(1), 47–64. PubMed · PMID 22796576
    DOI : 10.1016/j.yfrne.2012.07.001

    Contenus utilisant cette ressource : Vitamine D3

  11. Kennedy DO, Little W, Scholey AB. (2004). Attenuation of laboratory-induced stress in humans after acute administration of Melissa officinalis (Lemon Balm). Psychosomatic Medicine, 66(4), 607–613. https://doi.org/10.1097/01.psy.0000132877.72833.71 PubMed · PMID 15272110
    DOI: 10.1097/01.psy.0000132877.72833.71

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  12. Canal N, et al. (1991). Effect of L-alpha-glyceryl-phosphorylcholine on amnesia caused by scopolamine. International Journal of Clinical Pharmacology, Therapy, and Toxicology, 29(3), 103–107. PubMed · PMID 2071257

    Contenus utilisant cette ressource : Alpha-GPC

  13. Giesbrecht, T. et al. (2010). The combination of L-Theanine and caffeine improves cognitive performance and increases subjective alertness. Nutritional Neuroscience, 13(6), 283–290. PubMed · PMID 21040626
    DOI : 10.1179/147683010X12611460764840

    Contenus utilisant cette ressource : Caféine et L-théanine : études sur l’attention et limites

  14. Geng J, et al. (2010). Ginseng for cognition. Cochrane Database of Systematic Reviews, (12), CD007769. PubMed · PMID 21154383
    DOI: 10.1002/14651858.CD007769.pub2

    Contenus utilisant cette ressource : Panax Ginseng

  15. Le Bars PL, et al. (1997). A placebo-controlled, double-blind, randomized trial of an extract of Ginkgo biloba for dementia. North American EGb Study Group. JAMA, 278(16), 1327–1332. PubMed · PMID 9343463
    DOI: 10.1001/jama.278.16.1327

    Contenus utilisant cette ressource : Ginkgo Biloba

  16. Liu T, et al. (2025). Efficacy and safety of L-oxiracetam on cognitive function in patients with traumatic brain injury: a multicentre, randomised, double-blind, phase 3 clinical trial. Signal Transduction and Targeted Therapy, 10, 401. https://doi.org/10.1038/s41392-025-02492-5 PubMed · PMID 41381424
    DOI: 10.1038/s41392-025-02492-5

    Contenus utilisant cette ressource : Oxiracétam

  17. Hausenblas HA, et al. (2013). Saffron (Crocus sativus L.) and major depressive disorder: a meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. PubMed · PMID 24299602
    DOI : 10.3736/jintegrmed2013056

    Contenus utilisant cette ressource : Extrait de Safran

  18. Linde K, et al. (2008). St John's wort for major depression. Cochrane Database of Systematic Reviews. PubMed · PMID 18843608
    DOI: 10.1002/14651858.CD000448.pub3

    Contenus utilisant cette ressource : Millepertuis

  19. Birdsall TC. (1998). 5-Hydroxytryptophan: a clinically-effective serotonin precursor. Alternative Medicine Review, 3(4), 271–280. PubMed · PMID 9727088

    Contenus utilisant cette ressource : 5-HTP

  20. Soininen H, et al. (2021). 36-month LipiDiDiet multinutrient clinical trial in prodromal Alzheimer's disease. Alzheimer's & dementia : the journal of the Alzheimer's Association, 17(1), 29-40. https://doi.org/10.1002/alz.12172 PubMed · PMID 32920957
    DOI: 10.1002/alz.12172

    Contenus utilisant cette ressource : Monophosphate d'uridine

  21. Chandrasekhar K, Kapoor J, Anishetty S. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. PubMed · PMID 23439798
    DOI : 10.4103/0253-7176.106022

    Contenus utilisant cette ressource : ashwagandha

  22. Ferracioli-Oda E, Qawasmi A, Bloch MH. (2013). Meta-analysis: melatonin for the treatment of primary sleep disorders. PLOS ONE, 8(5), e63773. PubMed · PMID 23691095
    DOI: 10.1371/journal.pone.0063773

    Contenus utilisant cette ressource : mélatonine

  23. Brondino N, et al. (2013). A systematic review and meta-analysis of Ginkgo biloba in neuropsychiatric disorders: from ancient tradition to modern-day medicine. Evidence-Based Complementary and Alternative Medicine, 2013, 915691. PubMed · PMID 23781271
    DOI : 10.1155/2013/915691

    Contenus utilisant cette ressource : Ginkgo Biloba

  24. Sun Q, et al. (2016). Taurine Supplementation Lowers Blood Pressure and Improves Vascular Function in Prehypertension: Randomized, Double-Blind, Placebo-Controlled Study. Hypertension, 67(3), 541-9. https://doi.org/10.1161/HYPERTENSIONAHA.115.06624 PubMed · PMID 26781281
    DOI: 10.1161/HYPERTENSIONAHA.115.06624

    Contenus utilisant cette ressource : taureau

  25. Ghandforoush-Sattari M, et al. (2010). Pharmacokinetics of oral taurine in healthy volunteers. Journal of amino acids, 2010, 346237. https://doi.org/10.4061/2010/346237 PubMed · PMID 22331997
    DOI: 10.4061/2010/346237

    Contenus utilisant cette ressource : taureau

  26. Stough C, et al. (2001). The chronic effects of an extract of Bacopa monniera (Brahmi) on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481–484. PubMed · PMID 11498727
    DOI : 10.1007/s002130100815

    Contenus utilisant cette ressource : Bacopa Monnieri

  27. McEwen BS, Milner TA. (2007). Hippocampal formation: shedding light on the influence of sex and stress on the brain. Brain Research Reviews, 55(2), 343–355. PubMed · PMID 17395265
    DOI : 10.1016/j.brainresrev.2007.02.006

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  28. Di Stefano G, et al. (2019). Acetyl-L-carnitine in painful peripheral neuropathy: a systematic review. Journal of Pain Research, 12, 1341–1351. https://doi.org/10.2147/JPR.S190231 PubMed · PMID 31118753
    DOI: 10.2147/JPR.S190231

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  29. Stites T, et al. (2006). Pyrroloquinoline quinone modulates mitochondrial quantity and function in mice. Journal of Nutrition, 136(2), 390–396. PubMed · PMID 16424117
    DOI : 10.1093/jn/136.2.390

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  30. NIH NIDDK. LiverTox: Lion’s Mane. https://www.ncbi.nlm.nih.gov/books/NBK599740/ NIH NIDDK / LiverTox

    Contenus utilisant cette ressource : Crinière de Lion

  31. El Idrissi A, Trenkner E. (2004). Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochemical Research, 29(1), 189–197. PubMed · PMID 14992278
    DOI : 10.1023/b:where.0000010448.17740.6e

    Contenus utilisant cette ressource : taureau

  32. Dávalos A, et al. (2012). Citicoline in the treatment of acute ischaemic stroke: an international, randomised, multicentre, placebo-controlled study (ICTUS trial). The Lancet, 380(9839), 349–357. PubMed · PMID 22691567
    DOI: 10.1016/S0140-6736(12)60813-7

    Contenus utilisant cette ressource : CDP-Choline

  33. Calabrese C, et al. (2008). Effects of a standardized Bacopa monnieri extract on cognitive performance, anxiety, and depression in the elderly: a randomized, double-blind, placebo-controlled trial. Journal of Alternative and Complementary Medicine, 14(6), 707–713. PubMed · PMID 18611150
    DOI : 10.1089/acm.2008.0018

    Contenus utilisant cette ressource : Bacopa Monnieri

  34. Noorbala AA, Akhondzadeh S, et al. (2005). Hydro-alcoholic extract of Crocus sativus L. versus fluoxetine in the treatment of mild to moderate depression: a double-blind, randomized pilot trial. Journal of Ethnopharmacology, 97(2), 281–284. PubMed · PMID 15707766
    DOI: 10.1016/j.jep.2004.11.004

    Contenus utilisant cette ressource : Extrait de Safran

  35. Gohil, K.J., Patel, J.A., Gajjar, A.K. (2010). Pharmacological review on Centella asiatica: A potential herbal cure-all. Indian Journal of Pharmaceutical Sciences, 72(5), 546–556. PubMed · PMID 21694984
    DOI : 10.4103/0250-474X.78519

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  36. Abbasi B, et al. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences, 17(12), 1161–1169. PubMed · PMID 23853635

    Contenus utilisant cette ressource : Sommeil et nootropiques : études humaines et limites

  37. National Center for Complementary and Integrative Health. St. John’s Wort: Usefulness and Safety. https://www.nccih.nih.gov/health/st-johns-wort NIH NCCIH

    Contenus utilisant cette ressource : Millepertuis

  38. Misra HS, et al. (2012). Pyrroloquinoline-quinone and its versatile roles in biological processes. Journal of Biosciences, 37(2), 313–325. PubMed · PMID 22581337
    DOI : 10.1007/s12038-012-9195-5

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  39. Fernandez ME, et al. (2025). Is taurine an aging biomarker?. Science, 388(6751), eadl2116. https://doi.org/10.1126/science.adl2116 PubMed · PMID 40472098
    DOI: 10.1126/science.adl2116

    Contenus utilisant cette ressource : taureau

  40. Darbinyan V, et al. (2000). Rhodiola rosea in stress induced fatigue - a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine, 7(5), 365–371. PubMed · PMID 11081987
    DOI : 10.1016/S0944-7113(00)80055-0

    Contenus utilisant cette ressource : rhodiola rosea

  41. Lecaillon JB, et al. (1990). Pharmacokinetics of oxiracetam in patients with renal impairment after a 800 mg single oral dose. European Journal of Drug Metabolism and Pharmacokinetics, 15(3), 231–7. https://doi.org/10.1007/BF03190209 PubMed · PMID 2253654
    DOI: 10.1007/BF03190209

    Contenus utilisant cette ressource : Oxiracétam

  42. Parnetti L, et al. (2007). Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? Journal of the Neurological Sciences, 257(1-2), 264–269. PubMed · PMID 17331541
    DOI: 10.1016/j.jns.2007.01.043

    Contenus utilisant cette ressource : Alpha-GPC

  43. European Food Safety Authority (EFSA). (2009). The use of taurine and D-glucurono-gamma-lactone as constituents of the so-called “energy” drinks. EFSA Journal, 7(2), 935. https://doi.org/10.2903/j.efsa.2009.935 Notice éditeur · DOI · European Food Safety Authority
    DOI: 10.2903/j.efsa.2009.935

    Contenus utilisant cette ressource : taureau

  44. Slutsky I, et al. (2010). Enhancement of learning and memory by elevating brain magnesium. Neuron, 65(2), 165–177. PubMed · PMID 20152124
    DOI : 10.1016/j.neuron.2009.12.026

    Contenus utilisant cette ressource : Mg L-Thréonate Neuroplasticité : mécanismes, données humaines et limites de la recherche Débuter avec les nootropiques : limites des preuves et de la sécurité Vitamines, minéraux et cerveau : preuves sur les carences et compléments

  45. US Food and Drug Administration. FDA 101: Dietary Supplements. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements US Food and Drug Administration

    Contenus utilisant cette ressource : NMN

  46. Alvarez-Sabín J, Román GC. (2013). The role of citicoline in neuroprotection and neurorepair in ischemic stroke. Brain Sciences, 3(3), 1395–1414. PubMed · PMID 24961534
    DOI: 10.3390/brainsci3031395

    Contenus utilisant cette ressource : CDP-Choline

  47. LaRowe SD, et al. (2007). Is cocaine desire reduced by N-acetylcysteine? American Journal of Psychiatry, 164(7), 1115–1117. PubMed · PMID 17606664
    DOI: 10.1176/ajp.2007.164.7.1115

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  48. Lupien SJ, et al. (1998). Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nature neuroscience, 1(1), 69-73. PubMed · PMID 10195112
    DOI: 10.1038/271

    Contenus utilisant cette ressource : Stress et cortisol : mesures humaines et recherche sur les compléments

  49. Sarris J, et al. (2022). N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 117, 110550. https://doi.org/10.1016/j.pnpbp.2022.110550 PubMed · PMID 35304155
    DOI: 10.1016/j.pnpbp.2022.110550

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  50. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). (2024). Citicoline and support of the memory function: Evaluation of a health claim. https://www.efsa.europa.eu/en/efsajournal/pub/8861 European Food Safety Authority

    Contenus utilisant cette ressource : CDP-Choline

  51. Berk M, et al. (2008). N-acetyl cysteine as a glutathione precursor for schizophrenia--a double-blind, randomized, placebo-controlled trial. Biological Psychiatry, 64(5), 361–368. PubMed · PMID 18436195
    DOI: 10.1016/j.biopsych.2008.03.004

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  52. Winblad B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11(2), 169–182. PubMed · PMID 16007238
    DOI : 10.1111/j.1527-3458.2005.tb00268.x

    Contenus utilisant cette ressource : Stacks nootropiques : preuves et risques de cinq associations

  53. Sapolsky RM. (1996). Why stress is bad for your brain. Science, 273(5276), 749–750. PubMed · PMID 8701325
    DOI : 10.1126/science.273.5276.749

    Contenus utilisant cette ressource : Stress et cortisol : mesures humaines et recherche sur les compléments

  54. NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Mg L-Thréonate

  55. Kongkeaw C, et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri. Journal of Ethnopharmacology, 151(1), 528–535. PubMed · PMID 24252493
    DOI : 10.1016/j.jep.2013.11.008

    Contenus utilisant cette ressource : Débuter avec les nootropiques : limites des preuves et de la sécurité

  56. Roodenrys S, et al. (2002). Chronic effects of Brahmi (Bacopa monnieri) on human memory. Neuropsychopharmacology, 27(2), 279–281. PubMed · PMID 12093601
    DOI : 10.1016/S0893-133X(01)00419-5

    Contenus utilisant cette ressource : Bacopa Monnieri

  57. Müller, W.E. et al. (1997). Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. Biochemical Pharmacology, 53(2), 135–140. PubMed · PMID 9037245
    DOI: 10.1016/s0006-2952(96)00463-7

    Contenus utilisant cette ressource : Piracétam

  58. Yoshino M, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science, 372(6547), 1224–1229. PubMed · PMID 33888596
    DOI : 10.1126/science.abe9985

    Contenus utilisant cette ressource : NMN Mitochondries et énergie cérébrale : mécanismes et preuves Vieillissement cérébral : limites des recherches sur les nootropiques

  59. US Food and Drug Administration. Phenibut in Dietary Supplements. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/phenibut-dietary-supplements US Food and Drug Administration

    Contenus utilisant cette ressource : phénibut

  60. Lu B, Nagappan G, Lu Y. (2014). BDNF and synaptic plasticity, cognitive function, and dysfunction. Handbook of Experimental Pharmacology, 220, 223–250. PubMed · PMID 24668475
    DOI: 10.1007/978-3-642-45106-5_9

    Contenus utilisant cette ressource : Neuroplasticité : mécanismes, données humaines et limites de la recherche

  61. Hausenblas HA, et al. (2013). Saffron (Crocus sativus L.) and major depressive disorder: A meta-analysis of randomized clinical trials. Journal of Integrative Medicine, 11(6), 377–383. PubMed · PMID 24299602
    DOI : 10.3736/jintegrmed2013056

    Contenus utilisant cette ressource : Dépression et anxiété : preuves et risques des compléments naturels

  62. Mori K, et al. (2009). Improving effects of the mushroom Yamabushitake (Hericium erinaceus) on mild cognitive impairment: a double-blind placebo-controlled clinical trial. Phytotherapy Research, 23(3), 367–372. PubMed · PMID 18844328
    DOI : 10.1002/ptr.2634

    Contenus utilisant cette ressource : Crinière de Lion Neuroplasticité : mécanismes, données humaines et limites de la recherche Débuter avec les nootropiques : limites des preuves et de la sécurité Stacks nootropiques : preuves et risques de cinq associations Vieillissement cérébral : limites des recherches sur les nootropiques

  63. DailyMed. Phenelzine sulfate: US prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=fa041652-fdde-4794-a8d2-279dd309e075 DailyMed / US National Library of Medicine

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine L-Tyrosine

  64. Salehi, B. et al. (2019). The therapeutic potential of apigenin. International Journal of Molecular Sciences, 20(6), 1305. (Genel derlemedir; spesifik mekanizma iddiaları için orijinal çalışmalar incelenmelidir.) PubMed · PMID 30875872
    DOI: 10.3390/ijms20061305

    Contenus utilisant cette ressource : Apigénine

  65. Patel YA, Marzella N. (2017). Dietary Supplement-Drug Interaction-Induced Serotonin Syndrome Progressing to Acute Compartment Syndrome. American Journal of Case Reports, 18, 926–930. PubMed · PMID 28839121
    DOI: 10.12659/AJCR.904375

    Contenus utilisant cette ressource : 5-HTP

  66. NIH NCCIH. Turmeric: Usefulness and Safety. https://www.nccih.nih.gov/health/turmeric NIH NCCIH

    Contenus utilisant cette ressource : curcumine Vieillissement cérébral : limites des recherches sur les nootropiques

  67. Owen GN, et al. (2008). The combined effects of L-Theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience, 11(4), 193–198. PubMed · PMID 18681988
    DOI : 10.1179/147683008X301513

    Contenus utilisant cette ressource : L-Théanine Stacks nootropiques : preuves et risques de cinq associations

  68. Kato-Kataoka A, et al. (2010). Soybean-derived phosphatidylserine improves memory function of the elderly Japanese subjects with memory complaints. Journal of Clinical Biochemistry and Nutrition, 47(3), 246–255. PubMed · PMID 21103034
    DOI: 10.3164/jcbn.10-62

    Contenus utilisant cette ressource : Phosphatidylsérine

  69. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands-A review. Journal of Psychiatric Research, 70, 50–57. PubMed · PMID 26424423
    DOI: 10.1016/j.jpsychires.2015.08.014

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  70. Lai PL, et al. (2013). Neurotrophic properties of the Lion's mane medicinal mushroom, Hericium erinaceus (Higher Basidiomycetes) from Malaysia. International Journal of Medicinal Mushrooms, 15(6), 539–554. PubMed · PMID 24266378
    DOI: 10.1615/intjmedmushr.v15.i6.30

    Contenus utilisant cette ressource : Crinière de Lion

  71. Reay JL, Kennedy DO, Scholey AB. (2005). Single doses of Panax ginseng (G115) reduce blood glucose levels and improve cognitive performance during sustained mental activity. Journal of Psychopharmacology, 19(4), 357–365. PubMed · PMID 15982990
    DOI : 10.1177/0269881105053286

    Contenus utilisant cette ressource : Panax Ginseng

  72. Stabler SP. (2013). Clinical practice. Vitamin B12 deficiency. New England Journal of Medicine, 368(2), 149–160. PubMed · PMID 23301732
    DOI: 10.1056/NEJMcp1113996

    Contenus utilisant cette ressource : Vitamines, minéraux et cerveau : preuves sur les carences et compléments

  73. Lyon MR, et al. (2011). The effects of L-theanine (Suntheanine®) on objective sleep quality in boys with attention deficit hyperactivity disorder (ADHD): a randomized, double-blind, placebo-controlled clinical trial. Alternative Medicine Review, 16(4), 348–354. PubMed · PMID 22214254

    Contenus utilisant cette ressource : L-Théanine

  74. National Center for Complementary and Integrative Health. Berberine and Weight Loss: What You Need To Know. https://www.nccih.nih.gov/health/berberine-and-weight-loss-what-you-need-to-know NIH NCCIH

    Contenus utilisant cette ressource : Berbérine

  75. Bloch MH, et al. (2013). N-Acetylcysteine in the treatment of pediatric trichotillomania: a randomized, double-blind, placebo-controlled add-on trial. Journal of the American Academy of Child and Adolescent Psychiatry, 52(3), 231-40. https://doi.org/10.1016/j.jaac.2012.12.020 PubMed · PMID 23452680
    DOI: 10.1016/j.jaac.2012.12.020

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  76. Kang JH, et al. (2022). Marine n-3 fatty acids and cognitive change among older adults in the VITAL randomized trial. Alzheimer's & Dementia (New York, NY), 8(1), e12288. https://doi.org/10.1002/trc2.12288 PubMed · PMID 35415212
    DOI: 10.1002/trc2.12288

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  77. Talbott SM, et al. (2013). Effect of Tongkat Ali on stress hormones and psychological mood state in moderately stressed subjects. Journal of the International Society of Sports Nutrition, 10, 28. PubMed · PMID 23705671
    DOI: 10.1186/1550-2783-10-28

    Contenus utilisant cette ressource : Tongkat Ali Stress et cortisol : mesures humaines et recherche sur les compléments

  78. Flynn Pharma. Circadin 2 mg Prolonged-release Tablets: Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/2809/smpc Flynn Pharma / electronic medicines compendium

    Contenus utilisant cette ressource : mélatonine

  79. World Anti-Doping Agency. The 2026 Prohibited List. https://www.wada-ama.org/sites/default/files/2025-09/2026list_en_final_clean_september_2025.pdf World Anti-Doping Agency

    Contenus utilisant cette ressource : Phénylpiracétam

  80. Malykh AG & Sadaie MR (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs, 70(3), 287–312. PubMed · PMID 20166767
    DOI : 10.2165/11319230-000000000-00000

    Contenus utilisant cette ressource : Phénylpiracétam

  81. Ferris SH, et al. (1977). Senile dementia: treatment with deanol. Journal of the American Geriatrics Society, 25(6), 241–244. PubMed · PMID 864168
    DOI : 10.1111/j.1532-5415.1977.tb00407.x

    Contenus utilisant cette ressource : DMAE

  82. Zhang C, et al. (2022). A Magtein®, Magnesium L-Threonate, -Based Formula Improves Brain Cognitive Functions in Healthy Chinese Adults. Nutrients, 14(24), 5235. PubMed · PMID 36558392
    DOI : 10.3390/nu14245235

    Contenus utilisant cette ressource : Mg L-Thréonate

  83. Storch, A. et al. (2007). Randomized, double-blind, placebo-controlled trial on symptomatic effects of coenzyme Q(10) in Parkinson disease. Archives of Neurology, 64(7), 938–944. PubMed · PMID 17502459
    DOI: 10.1001/archneur.64.7.nct60005

    Contenus utilisant cette ressource : Coenzyme Q10

  84. Pizzi M, et al. (1993). Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. Journal of Neurochemistry, 61(2), 683–9. https://doi.org/10.1111/j.1471-4159.1993.tb02173.x PubMed · PMID 8101561
    DOI: 10.1111/j.1471-4159.1993.tb02173.x

    Contenus utilisant cette ressource : aniracétam

  85. Müller U, et al. (2013). Effects of modafinil on non-verbal cognition, task enjoyment and creative thinking in healthy volunteers. Neuropharmacology, 64(5), 490–495. PubMed · PMID 22820554
    DOI: 10.1016/j.neuropharm.2012.07.009

    Contenus utilisant cette ressource : modafinil

  86. Magnusson I, et al. (1989). N-acetyl-L-tyrosine and N-acetyl-L-cysteine as tyrosine and cysteine precursors during intravenous infusion in humans. Metabolism, 38(10), 957–61. https://doi.org/10.1016/0026-0495(89)90005-x PubMed · PMID 2507878
    DOI: 10.1016/0026-0495(89)90005-x

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  87. Hidese S, et al. (2019). Effects of L-Theanine Administration on Stress-Related Symptoms and Cognitive Functions in Healthy Adults: A Randomized Controlled Trial. Nutrients, 11(10), 2362. PubMed · PMID 31623400
    DOI: 10.3390/nu11102362

    Contenus utilisant cette ressource : Sommeil et nootropiques : études humaines et limites

  88. Kamgar E, et al. (2025). Quantifying of thallium in Shilajit and its supplements to unveil the potential risk of consumption of this popular traditional medicine. BMC chemistry, 19(1), 20. PubMed · PMID 39827344
    DOI: 10.1186/s13065-025-01384-7

    Contenus utilisant cette ressource : shilajit

  89. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands--A review. Journal of Psychiatric Research, 70, 50–57. PubMed · PMID 26424423
    DOI: 10.1016/j.jpsychires.2015.08.014

    Contenus utilisant cette ressource : L-Tyrosine

  90. Samokhvalov AV, et al. (2013). Phenibut dependence. BMJ Case Reports. PubMed · PMID 23391959
    DOI : 10.1136/bcr-2012-008381

    Contenus utilisant cette ressource : phénibut

  91. Calder PC (2016). Docosahexaenoic acid. Annals of Nutrition and Metabolism, 69(Suppl 1), 7–21. PubMed · PMID 27842299
    DOI: 10.1159/000448262

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  92. Rainey-Smith SR, et al. (2016). Curcumin and cognition: a randomised, placebo-controlled, double-blind study of community-dwelling older adults. British Journal of Nutrition, 115(12), 2106–13. https://doi.org/10.1017/S0007114516001203 PubMed · PMID 27102361
    DOI: 10.1017/S0007114516001203

    Contenus utilisant cette ressource : curcumine

  93. Kongkeaw C, et al. (2014). Meta-analysis of randomized controlled trials on cognitive effects of Bacopa monnieri extract. Journal of Ethnopharmacology, 151(1), 528–535. PubMed · PMID 24252493
    DOI : 10.1016/j.jep.2013.11.008

    Contenus utilisant cette ressource : Bacopa Monnieri

  94. Koetter U, et al. (2007). A randomized, double blind, placebo-controlled, prospective clinical study to demonstrate clinical efficacy of a fixed valerian hops extract combination (Ze 91019) in patients suffering from non-organic sleep disorder. Phytotherapy Research, 21(9), 847–851. PubMed · PMID 17486686
    DOI: 10.1002/ptr.2167

    Contenus utilisant cette ressource : Valériane (Valeriana)

  95. Dean O, et al. (2011). N-acetylcysteine in psychiatry: current therapeutic evidence and potential mechanisms of action. Journal of Psychiatry & Neuroscience, 36(2), 78–86. PubMed · PMID 21118657
    DOI : 10.1503/jpn.100057

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  96. ANSM · Base de Données Publique des Médicaments. ARCALION 200 mg, comprimé enrobé: Résumé des caractéristiques du produit. https://base-donnees-publique.medicaments.gouv.fr/medicament/64384738/extrait ANSM · Base de Données Publique des Médicaments

    Contenus utilisant cette ressource : Sulbutiamine

  97. US Food and Drug Administration. (2019). Warning Letter: Peak Nootropics LLC aka Advanced Nootropics. https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/warning-letters/peak-nootropics-llc-aka-advanced-nootropics-557887-02052019 US Food and Drug Administration

    Contenus utilisant cette ressource : noopept aniracétam Oxiracétam pramiracétam

  98. DailyMed. Carbidopa and levodopa: US prescribing information. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3f6d393e-ac84-4a3c-a837-199d1ec71fd2 DailyMed / US National Library of Medicine

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine L-Tyrosine

  99. Spagnoli A, et al. (1991). Long-term acetyl-L-carnitine treatment in Alzheimer's disease. Neurology, 41(11), 1726–1732. PubMed · PMID 1944900
    DOI : 10.1212/wnl.41.11.1726

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  100. NIH NIDDK. LiverTox: Centella asiatica. https://www.ncbi.nlm.nih.gov/books/NBK603561/ NIH NIDDK / LiverTox

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  101. Gencer B, et al. (2021). Effect of Long-Term Marine ɷ-3 Fatty Acids Supplementation on the Risk of Atrial Fibrillation in Randomized Controlled Trials of Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Circulation, 144(25), 1981-1990. https://doi.org/10.1161/CIRCULATIONAHA.121.055654 PubMed · PMID 34612056
    DOI: 10.1161/CIRCULATIONAHA.121.055654

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  102. Burckhardt M, et al. (2020). Souvenaid for Alzheimer's disease. The Cochrane database of systematic reviews, 12(12), CD011679. https://doi.org/10.1002/14651858.CD011679.pub2 PubMed · PMID 33320335
    DOI: 10.1002/14651858.CD011679.pub2

    Contenus utilisant cette ressource : Monophosphate d'uridine

  103. Zhang H, et al. (2010). Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism, 59(2), 285–292. PubMed · PMID 19800084
    DOI : 10.1016/j.metabol.2009.07.029

    Contenus utilisant cette ressource : Berbérine

  104. ADVANZ Pharma. Nootropil 1200 mg film-coated tablets: Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/101131/smpc ADVANZ Pharma / electronic medicines compendium

    Contenus utilisant cette ressource : Piracétam

  105. Katzenschlager R, et al. (2004). Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. Journal of Neurology, Neurosurgery & Psychiatry, 75(12), 1672–1677. PubMed · PMID 15548480
    DOI : 10.1136/jnnp.2003.028761

    Contenus utilisant cette ressource : Mucuna Pruriens

  106. Bhatt JK, et al. (2012). Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutrition Research, 32(7), 537–541. PubMed · PMID 22901562
    DOI : 10.1016/j.nutres.2012.06.003

    Contenus utilisant cette ressource : Vieillissement cérébral : limites des recherches sur les nootropiques

  107. Rae C, et al. (2003). Oral creatine monohydrate supplementation improves brain performance: a double-blind, placebo-controlled, cross-over trial. Proceedings of the Royal Society B: Biological Sciences, 270(1529), 2147–2150. PubMed · PMID 14561278
    DOI : 10.1098/rspb.2003.2492

    Contenus utilisant cette ressource : Créatine

  108. Watanabe A, et al. (2002). Effects of creatine on mental fatigue and cerebral hemoglobin oxygenation. Neuroscience Research, 42(4), 279–285. PubMed · PMID 11985880
    DOI : 10.1016/s0168-0102(02)00007-x

    Contenus utilisant cette ressource : Créatine

  109. Lampariello LR, et al. (2012). The magic velvet bean of Mucuna pruriens. Journal of Traditional and Complementary Medicine, 2(4), 331–339. PubMed · PMID 24716148
    DOI : 10.1016/s2225-4110(16)30119-5

    Contenus utilisant cette ressource : Dopamine et motivation : limites des preuves sur les nootropiques

  110. Cases J, et al. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism, 4(3), 211–218. PubMed · PMID 22207903
    DOI: 10.1007/s12349-010-0045-4

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  111. Cox KH, et al. (2015). Investigation of the effects of solid lipid curcumin on cognition and mood in a healthy older population. Journal of Psychopharmacology, 29(5), 642–651. PubMed · PMID 25277322
    DOI: 10.1177/0269881114552744

    Contenus utilisant cette ressource : curcumine

  112. Oliver JM, et al. (2016). Effect of docosahexaenoic acid on a biomarker of head trauma in American football. Medicine and Science in Sports and Exercise, 48(6), 974–982. PubMed · PMID 26765633
    DOI : 10.1249/MSS.0000000000000875

    Contenus utilisant cette ressource : Performance cérébrale des sportifs : preuves et limites des compléments

  113. Auld F, et al. (2017). Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Medicine Reviews, 34, 10–22. PubMed · PMID 28648359
    DOI : 10.1016/j.smrv.2016.06.005

    Contenus utilisant cette ressource : mélatonine

  114. Han P, et al. (2026). Stage-Dependent Cognitive Effects of a Multinutrient Intervention in Alzheimer's Disease: A Stage-Stratified Meta-Analysis. Journal of Visualized Experiments, (235). https://doi.org/10.3791/72385 PubMed · PMID 42683892
    DOI: 10.3791/72385

    Contenus utilisant cette ressource : Monophosphate d'uridine

  115. Barth C, et al. (2015). Sex hormones affect neurotransmitters and shape the adult female brain during hormonal transition periods. Frontiers in Neuroscience, 9, 37. PubMed · PMID 25750611
    DOI : 10.3389/fnins.2015.00037

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  116. Shukla KK, et al. (2010). Mucuna pruriens Reduces Stress and Improves the Quality of Semen in Infertile Men. Evidence-Based Complementary and Alternative Medicine, 7(1), 137–144. https://doi.org/10.1093/ecam/nem171 PubMed · PMID 18955292
    DOI: 10.1093/ecam/nem171

    Contenus utilisant cette ressource : Mucuna Pruriens Dopamine et motivation : limites des preuves sur les nootropiques

  117. Boyle NB, et al. (2017). The Effects of Magnesium Supplementation on Subjective Anxiety and Stress-A Systematic Review. Nutrients, 9(5), 429. PubMed · PMID 28445426
    DOI: 10.3390/nu9050429

    Contenus utilisant cette ressource : Dépression et anxiété : preuves et risques des compléments naturels

  118. Glade MJ, Smith K. (2015). Phosphatidylserine and the human brain. Nutrition, 31(6), 781–786. PubMed · PMID 25933483
    DOI : 10.1016/j.nut.2014.10.014

    Contenus utilisant cette ressource : Phosphatidylsérine

  119. Appleton KM, et al. (2021). Omega-3 fatty acids for depression in adults. The Cochrane database of systematic reviews, 11(11), CD004692. https://doi.org/10.1002/14651858.CD004692.pub5 PubMed · PMID 34817851
    DOI: 10.1002/14651858.CD004692.pub5

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  120. Haskell, C.F. et al. (2008). The effects of L-Theanine, caffeine and their combination on cognition and mood. Biological Psychology, 77(2), 113–122. PubMed · PMID 18006208
    DOI : 10.1016/j.biopsycho.2007.09.008

    Contenus utilisant cette ressource : Caféine et L-théanine : études sur l’attention et limites

  121. McLean A Jr, et al. (1991). Placebo-controlled study of pramiracetam in young males with memory and cognitive problems resulting from head injury and anoxia. Brain Injury, 5(4), 375–80. https://doi.org/10.3109/02699059109008110 PubMed · PMID 1786500
    DOI: 10.3109/02699059109008110

    Contenus utilisant cette ressource : pramiracétam

  122. Cansev M, Wurtman RJ. (2007). Chronic administration of docosahexaenoic acid or eicosapentaenoic acid, but not arachidonic acid, alone or in combination with uridine, increases brain phosphatide and synaptic protein levels in gerbils. Neuroscience, 148(2), 421–431. PubMed · PMID 17683870
    DOI: 10.1016/j.neuroscience.2007.06.016

    Contenus utilisant cette ressource : Monophosphate d'uridine

  123. NIH NCCIH. Chamomile: Usefulness and Safety. https://www.nccih.nih.gov/health/chamomile NIH NCCIH

    Contenus utilisant cette ressource : Apigénine

  124. Scholey A, et al. (2010). Effects of American ginseng (Panax quinquefolius) on neurocognitive function: an acute, randomised, double-blind, placebo-controlled, crossover study. Psychopharmacology, 212(3), 345–356. PubMed · PMID 20676609
    DOI : 10.1007/s00213-010-1964-y

    Contenus utilisant cette ressource : Panax Ginseng

  125. McEwen BS. (2007). Physiology and neurobiology of stress and adaptation: central role of the brain. Physiological Reviews, 87(3), 873–904. PubMed · PMID 17615391
    DOI : 10.1152/physrev.00041.2006

    Contenus utilisant cette ressource : Stress et cortisol : mesures humaines et recherche sur les compléments

  126. Pandit S, et al. (2016). Clinical evaluation of purified Shilajit on testosterone levels in healthy volunteers. Andrologia, 48(5), 570–575. PubMed · PMID 26395129
    DOI : 10.1111/and.12482

    Contenus utilisant cette ressource : shilajit

  127. Yurko-Mauro K, et al. (2010). Beneficial effects of docosahexaenoic acid on cognition in age-related cognitive decline. Alzheimer's & Dementia, 6(6), 456–464. PubMed · PMID 20434961
    DOI: 10.1016/j.jalz.2010.01.013

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  128. Fioravanti M, Buckley AE. (2006). Citicoline (Cognizin) in the treatment of cognitive impairment. Clinical Interventions in Aging, 1(3), 247–251. PubMed · PMID 18046877
    DOI : 10.2147/ciia.2006.1.3.247

    Contenus utilisant cette ressource : CDP-Choline

  129. Gouliaev, A.H., Senning, A. (1994). Piracetam and other structurally related nootropics. Brain Research Reviews, 19(2), 180–222. PubMed · PMID 8061686
    DOI : 10.1016/0165-0173(94)90011-6

    Contenus utilisant cette ressource : Oxiracétam pramiracétam

  130. NIH Office of Dietary Supplements. Vitamin D: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Vitamine D3

  131. European Medicines Agency. Community herbal monograph on Melissa officinalis L., folium. https://www.ema.europa.eu/en/documents/herbal-monograph/final-community-herbal-monograph-melissa-officinalis-l-folium_en.pdf European Medicines Agency

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  132. Bellar D, et al. (2015). The effect of 6 days of alpha glycerylphosphorylcholine on isometric strength. Journal of the International Society of Sports Nutrition, 12, 42. PubMed · PMID 26582972
    DOI : 10.1186/s12970-015-0103-x

    Contenus utilisant cette ressource : Alpha-GPC

  133. National Institutes of Health, Office of Dietary Supplements. Carnitine: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/carnitine-healthprofessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  134. US National Library of Medicine · DailyMed. PROVIGIL (modafinil) prescribing information: Apotex label. https://www.dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0391f182-1958-9fef-a944-53b229ce99e7 US National Library of Medicine · DailyMed

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  135. Borrelli F, Izzo AA. (2009). Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations. AAPS Journal, 11(4), 710–727. PubMed · PMID 19859815
    DOI: 10.1208/s12248-009-9146-8

    Contenus utilisant cette ressource : Millepertuis

  136. Hypericum Depression Trial Study Group. (2002). Effect of Hypericum perforatum (St John's wort) in major depressive disorder: a randomized controlled trial. JAMA, 287(14), 1807–1814. PubMed · PMID 11939866
    DOI: 10.1001/jama.287.14.1807

    Contenus utilisant cette ressource : Millepertuis

  137. Voss MW, et al. (2013). Bridging animal and human models of exercise-induced brain plasticity. Trends in Cognitive Sciences, 17(10), 525–544. PubMed · PMID 24029446
    DOI : 10.1016/j.tics.2013.08.001

    Contenus utilisant cette ressource : Neuroplasticité : mécanismes, données humaines et limites de la recherche

  138. Graves JM, et al. (2020). Notes from the Field: Phenibut Exposures Reported to Poison Centers — United States, 2009–2019. MMWR, 69(35), 1227–1228. https://www.cdc.gov/mmwr/volumes/69/wr/mm6935a5.htm PubMed · PMID 32881852
    DOI: 10.15585/mmwr.mm6935a5

    Contenus utilisant cette ressource : phénibut

  139. Dai G, et al. (2001). CordyMax Cs-4 improves steady-state bioenergy status in mouse liver. Journal of Alternative and Complementary Medicine, 7(3), 231–40. https://doi.org/10.1089/107555301300328106 PubMed · PMID 11439844
    DOI: 10.1089/107555301300328106

    Contenus utilisant cette ressource : cordyceps

  140. Lagouge M, et al. (2006). Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1α. Cell, 127(6), 1109–1122. PubMed · PMID 17112576
    DOI : 10.1016/j.cell.2006.11.013

    Contenus utilisant cette ressource : resvératrol

  141. Sun QQ, et al. (1999). Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Zhongguo Yao Li Xue Bao, 20(7), 601–603. PubMed · PMID 10678121

    Contenus utilisant cette ressource : Huperzine A

  142. Suliman NA, et al. (2016). Establishing natural nootropics: recent molecular enhancement influenced by natural nootropic. Evidence-Based Complementary and Alternative Medicine, 2016, 4391375. PubMed · PMID 27656235
    DOI : 10.1155/2016/4391375

    Contenus utilisant cette ressource : Débuter avec les nootropiques : limites des preuves et de la sécurité

  143. Grant JE, et al. (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: a double-blind, placebo-controlled study. Archives of General Psychiatry, 66(7), 756–763. PubMed · PMID 19581567
    DOI: 10.1001/archgenpsychiatry.2009.60

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  144. Liao B, et al. (2021). Nicotinamide mononucleotide supplementation enhances aerobic capacity in amateur runners: a randomized, double-blind study. Journal of the International Society of Sports Nutrition, 18(1), 54. PubMed · PMID 34238308
    DOI: 10.1186/s12970-021-00442-4

    Contenus utilisant cette ressource : NMN

  145. Lopresti AL, Drummond PD. (2014). Saffron (Crocus sativus) for depression: a systematic review of clinical studies and examination of underlying antidepressant mechanisms of action. Human Psychopharmacology, 29(6), 517–527. PubMed · PMID 25384672
    DOI : 10.1002/hup.2434

    Contenus utilisant cette ressource : Extrait de Safran

  146. Wightman EL, et al. (2014). Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation. British Journal of Nutrition, 112(2), 203–13. https://doi.org/10.1017/S0007114514000737 PubMed · PMID 24804871
    DOI: 10.1017/S0007114514000737

    Contenus utilisant cette ressource : resvératrol

  147. Irie J, et al. (2020). Effect of oral administration of nicotinamide mononucleotide on clinical parameters and nicotinamide metabolite levels in healthy Japanese men. Endocrine Journal, 67(2), 153–160. PubMed · PMID 31685720
    DOI : 10.1507/endocrj.EJ19-0313

    Contenus utilisant cette ressource : NMN

  148. Facchinetti F, et al. (1991). Oral magnesium successfully relieves premenstrual mood changes. Obstetrics and Gynecology, 78(2), 177–181. PubMed · PMID 2067759

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  149. Hindmarch I, et al. (1991). Efficacy and tolerance of vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. International Clinical Psychopharmacology, 6(1), 31–43. PubMed · PMID 2071888
    DOI : 10.1097/00004850-199100610-00005

    Contenus utilisant cette ressource : vinpocétine

  150. Freeman MP, et al. (2006). Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. Journal of Clinical Psychiatry, 67(12), 1954–1967. PubMed · PMID 17194275
    DOI : 10.4088/jcp.v67n1217

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  151. Viola, H. et al. (1995). Apigenin, a component of Matricaria recutita flowers, is a central benzodiazepine receptors-ligand with anxiolytic effects. Planta Medica, 61(3), 213–216. PubMed · PMID 7617761
    DOI : 10.1055/s-2006-958058

    Contenus utilisant cette ressource : Apigénine

  152. Talaei A, et al. (2015). Crocin, the main active saffron constituent, as an adjunctive treatment in major depressive disorder: a randomized, double-blind, placebo-controlled, pilot clinical trial. Journal of Affective Disorders, 174, 51–6. https://doi.org/10.1016/j.jad.2014.11.035 PubMed · PMID 25484177
    DOI: 10.1016/j.jad.2014.11.035

    Contenus utilisant cette ressource : Extrait de Safran

  153. Lopresti AL, Smith SJ. (2026). Correction: The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Frontiers in Nutrition, 13, 2010644. PubMed · PMID 42959782
    DOI: 10.3389/fnut.2026.2010644

    Contenus utilisant cette ressource : Mg L-Thréonate

  154. Health Canada. Summary of Health Canada’s safety assessment of phosphatidylserine for use as a supplemental ingredient. https://www.canada.ca/en/health-canada/services/food-nutrition/public-involvement-partnerships/modification-list-permitted-supplemental-ingredients-enable-use-phosphatidylserine-soy/summary.html Health Canada

    Contenus utilisant cette ressource : Phosphatidylsérine

  155. Citherlet T. (2026). Commentary: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, 13, 1716285. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2026.1716285/full Notice éditeur · DOI · Frontiers in Nutrition
    DOI: 10.3389/fnut.2026.1716285

    Contenus utilisant cette ressource : Créatine

  156. Subhan Z & Hindmarch I (1985). Psychopharmacological effects of vinpocetine in normal healthy volunteers. European Journal of Clinical Pharmacology, 28(5), 567–571. PubMed · PMID 3899677
    DOI : 10.1007/BF00544068

    Contenus utilisant cette ressource : vinpocétine

  157. Hudson SA, Tabet N. (2003). Acetyl-L-carnitine for dementia. Cochrane Database of Systematic Reviews, (2), CD003158. PubMed · PMID 12804452
    DOI: 10.1002/14651858.CD003158

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  158. Sandor, P.S. et al. (2005). Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology, 64(4), 713–715. PubMed · PMID 15728298
    DOI: 10.1212/01.WNL.0000151975.03598.ED

    Contenus utilisant cette ressource : Coenzyme Q10

  159. Moshiri E, et al. (2006). Crocus sativus L. (petal) in the treatment of mild-to-moderate depression: a double-blind, randomized and placebo-controlled trial. Phytomedicine, 13(9–10), 607–611. PubMed · PMID 16979327
    DOI: 10.1016/j.phymed.2006.08.006

    Contenus utilisant cette ressource : Extrait de Safran

  160. Wankhede S, et al. (2015). Examining the effect of Withania somnifera supplementation on muscle strength and recovery: a randomized controlled trial. Journal of the International Society of Sports Nutrition, 12, 43. PubMed · PMID 26609282
    DOI : 10.1186/s12970-015-0104-9

    Contenus utilisant cette ressource : ashwagandha

  161. Jang D, et al. (2025). Menstrual cycle effects on cognitive performance: A meta-analysis. PLoS ONE, 20(3), e0318576. https://doi.org/10.1371/journal.pone.0318576 PubMed · PMID 40096188
    DOI: 10.1371/journal.pone.0318576

    Contenus utilisant cette ressource : Nootropiques pour les femmes : cycle hormonal et performance cognitive

  162. NIH NCCIH. Ginkgo: Usefulness and Safety. https://www.nccih.nih.gov/health/ginkgo NIH NCCIH

    Contenus utilisant cette ressource : Ginkgo Biloba

  163. Pavlík A, Benesová O, Dlohozková N. (1987). Effects of nootropic drugs on brain cholinergic and dopaminergic transmission. Activitas Nervosa Superior, 29(1), 62–65. PubMed · PMID 3035858

    Contenus utilisant cette ressource : Oxiracétam pramiracétam

  164. Shukla KK, et al. (2009). Mucuna pruriens improves male fertility by its action on the hypothalamus-pituitary-gonadal axis. Fertility and Sterility, 92(6), 1934–1940. PubMed · PMID 18973898
    DOI: 10.1016/j.fertnstert.2008.09.045

    Contenus utilisant cette ressource : Mucuna Pruriens

  165. Nagano M, et al. (2010). Reduction of depression and anxiety by 4 weeks Hericium erinaceus intake. Biomedical Research, 31(4), 231–237. PubMed · PMID 20834180
    DOI : 10.2220/biomedres.31.231

    Contenus utilisant cette ressource : Crinière de Lion

  166. Cryan, J.F. et al. (2019). The Microbiota-Gut-Brain Axis. Physiological Reviews, 99(4), 1877–2013. PubMed · PMID 31460832
    DOI: 10.1152/physrev.00018.2018

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  167. Avgerinos KI, et al. (2018). Effects of creatine supplementation on cognitive function of healthy individuals: a systematic review of randomized controlled trials. Experimental Gerontology, 108, 166–173. PubMed · PMID 29704637
    DOI : 10.1016/j.exger.2018.04.013

    Contenus utilisant cette ressource : Créatine Mitochondries et énergie cérébrale : mécanismes et preuves

  168. Sonnenburg, J.L. & Bäckhed, F. (2016). Diet–microbiota interactions as moderators of human metabolism. Nature, 535, 56–64. PubMed · PMID 27383980
    DOI : 10.1038/nature18846

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  169. T.C. Tarım ve Orman Bakanlığı. Bir takviye edici gıdanın onaylı olup olmadığını nereden öğrenebiliriz? (2026). https://guvenilirgida.tarimorman.gov.tr/Haber/Detay/17314 T.C. Tarım ve Orman Bakanlığı

    Contenus utilisant cette ressource : ashwagandha Mg L-Thréonate Huperzine A Mucuna Pruriens Dopamine et motivation : limites des preuves sur les nootropiques

  170. Liu G, et al. (2016). Efficacy and Safety of MMFS-01, a Synapse Density Enhancer, for Treating Cognitive Impairment in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial. Journal of Alzheimer's Disease, 49(4), 971–990. PubMed · PMID 26519439
    DOI: 10.3233/JAD-150538

    Contenus utilisant cette ressource : Mg L-Thréonate

  171. Okereke OI, et al. (2020). Effect of Long-term Vitamin D3 Supplementation vs Placebo on Risk of Depression or Clinically Relevant Depressive Symptoms and on Change in Mood Scores: A Randomized Clinical Trial. JAMA, 324(5), 471-480. https://doi.org/10.1001/jama.2020.10224 PubMed · PMID 32749491
    DOI: 10.1001/jama.2020.10224

    Contenus utilisant cette ressource : Vitamine D3

  172. Mahoney CR, et al. (2007). Tyrosine supplementation mitigates working memory decrements during cold exposure. Physiology & Behavior, 92(4), 575–582. PubMed · PMID 17585971
    DOI : 10.1016/j.physbeh.2007.05.003

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine

  173. Hardman MI, et al. (2019). Phenibut withdrawal: a comprehensive literature review and illustrative case report. Bosnian Journal of Basic Medical Sciences. PubMed · PMID 30501608
    DOI : 10.17305/bjbms.2018.4008

    Contenus utilisant cette ressource : phénibut

  174. Hirsch KR, et al. (2017). Cordyceps militaris improves tolerance to high-intensity exercise after acute and chronic supplementation. Journal of Dietary Supplements, 14(1), 42–53. PubMed · PMID 27408987
    DOI : 10.1080/19390211.2016.1203386

    Contenus utilisant cette ressource : cordyceps

  175. Kondo DG, et al. (2011). Open-label uridine for treatment of depressed adolescents with bipolar disorder. Journal of Child and Adolescent Psychopharmacology, 21(2), 171–175. PubMed · PMID 21486171
    DOI : 10.1089/cap.2010.0054

    Contenus utilisant cette ressource : Monophosphate d'uridine

  176. Sublette ME, et al. (2011). Meta-analysis of the effects of eicosapentaenoic acid (EPA) in clinical trials in depression. Journal of Clinical Psychiatry, 72(12), 1577–1584. PubMed · PMID 21939614
    DOI : 10.4088/JCP.10m06634

    Contenus utilisant cette ressource : Dépression et anxiété : preuves et risques des compléments naturels Nootropiques pour les femmes : cycle hormonal et performance cognitive

  177. Awad R, et al. (2009). Bioassay-guided fractionation of lemon balm (Melissa officinalis L.) using an in vitro measure of GABA transaminase activity. Phytotherapy Research, 23(8), 1075–1081. PubMed · PMID 19165747
    DOI: 10.1002/ptr.2712

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  178. US National Library of Medicine. PROVIGIL (modafinil): Prescribing Information and Medication Guide. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=e16c26ad-7bc2-d155-3a5d-da83ad6492c8 US National Library of Medicine · DailyMed

    Contenus utilisant cette ressource : modafinil Cycles de nootropiques : preuves et limites

  179. Lopresti AL, et al. (2014). Curcumin for the treatment of major depression: a randomised, double-blind, placebo controlled study. Journal of Affective Disorders, 167, 368–375. PubMed · PMID 25046624
    DOI : 10.1016/j.jad.2014.06.001

    Contenus utilisant cette ressource : curcumine

  180. Zvejniece L, et al. (2015). R-phenibut binds to the α2-δ subunit of voltage-dependent calcium channels and exerts gabapentin-like anti-nociceptive effects. Pharmacology Biochemistry and Behavior, 137, 23–29. doi:10.1016/j.pbb.2015.07.014. PubMed · PMID 26234470
    DOI: 10.1016/j.pbb.2015.07.014

    Contenus utilisant cette ressource : phénibut

  181. Wilsher, C.R. et al. (1987). Piracetam and dyslexia: effects on reading tests. Journal of Clinical Psychopharmacology, 7(4), 230–237. PubMed · PMID 3305591

    Contenus utilisant cette ressource : Piracétam

  182. Bradwejn, J. et al. (2000). A double-blind, placebo-controlled study on the effects of Gotu Kola (Centella asiatica) on acoustic startle response in healthy subjects. Journal of Clinical Psychopharmacology, 20(6), 680–684. PubMed · PMID 11106141
    DOI: 10.1097/00004714-200012000-00015

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  183. Malykh, A.G., Sadaie, M.R. (2010). Piracetam and piracetam-like drugs: from basic science to novel clinical applications to CNS disorders. Drugs, 70(3), 287–312. PubMed · PMID 20166767
    DOI : 10.2165/11319230-000000000-00000

    Contenus utilisant cette ressource : Oxiracétam pramiracétam

  184. Grosso G, et al. (2014). Omega-3 fatty acids and depression: scientific evidence and biological mechanisms. Oxidative Medicine and Cellular Longevity, 2014, 313570. PubMed · PMID 24757497
    DOI : 10.1155/2014/313570

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  185. Turner EH, et al. (2006). Serotonin a la carte: supplementation with the serotonin precursor 5-hydroxytryptophan. Pharmacology & Therapeutics, 109(3), 325–338. PubMed · PMID 16023217
    DOI: 10.1016/j.pharmthera.2005.06.004

    Contenus utilisant cette ressource : 5-HTP

  186. Kawagishi H, et al. (1994). Erinacines A, B and C, strong stimulators of nerve growth factor (NGF)-synthesis, from the mycelia of Hericium erinaceum. Tetrahedron Letters, 35(10), 1569–1572. https://doi.org/10.1016/S0040-4039(00)76760-8 Notice éditeur · DOI · Elsevier
    DOI: 10.1016/S0040-4039(00)76760-8

    Contenus utilisant cette ressource : Crinière de Lion

  187. Rucker R, et al. (2009). Potential physiological importance of pyrroloquinoline quinone. Alternative Medicine Review, 14(3), 268–277. PubMed · PMID 19803551

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  188. Ostrovskaya, R.U. et al. (2008). Noopept stimulates the expression of NGF and BDNF in rat hippocampus. Bulletin of Experimental Biology and Medicine, 146(3), 334–337. PubMed · PMID 19240853
    DOI: 10.1007/s10517-008-0297-x

    Contenus utilisant cette ressource : noopept

  189. Richie JP Jr, et al. (2015). Randomized controlled trial of oral glutathione supplementation on body stores of glutathione. European Journal of Nutrition, 54(2), 251–63. https://doi.org/10.1007/s00394-014-0706-z PubMed · PMID 24791752
    DOI: 10.1007/s00394-014-0706-z

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  190. Dinan, T.G., Stanton, C., & Cryan, J.F. (2013). Psychobiotics: a novel class of psychotropic. Biological Psychiatry, 74(10), 720–726. PubMed · PMID 23759244
    DOI : 10.1016/j.biopsych.2013.05.001

    Contenus utilisant cette ressource : Axe intestin-cerveau et performance cognitive

  191. Parkinson Study Group QE3 Investigators, et al. (2014). A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. JAMA Neurology, 71(5), 543–52. https://doi.org/10.1001/jamaneurol.2014.131 PubMed · PMID 24664227
    DOI: 10.1001/jamaneurol.2014.131

    Contenus utilisant cette ressource : Coenzyme Q10 Mitochondries et énergie cérébrale : mécanismes et preuves

  192. Juliano LM, Griffiths RR. (2004). A critical review of caffeine withdrawal: empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology (Berl), 176(1), 1–29. doi:10.1007/s00213-004-2000-x. PubMed · PMID 15448977
    DOI: 10.1007/s00213-004-2000-x

    Contenus utilisant cette ressource : Cycles de nootropiques : preuves et limites

  193. Shaffer JA, et al. (2014). Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials. Psychosomatic Medicine, 76(3), 190–196. PubMed · PMID 24632894
    DOI: 10.1097/PSY.0000000000000044

    Contenus utilisant cette ressource : Vitamine D3

  194. Kang JH, et al. (2021). Effect of vitamin D on cognitive decline: results from two ancillary studies of the VITAL randomized trial. Scientific reports, 11(1), 23253. https://doi.org/10.1038/s41598-021-02485-8 PubMed · PMID 34853363
    DOI: 10.1038/s41598-021-02485-8

    Contenus utilisant cette ressource : Vitamine D3

  195. Mattson MP, et al. (2008). Mitochondria in neuroplasticity and neurological disorders. Neuron, 60(5), 748–766. PubMed · PMID 19081372
    DOI: 10.1016/j.neuron.2008.10.010

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : mécanismes et preuves

  196. Itil TM, Menon GN, Bozak M, Songar A. (1982). The effects of oxiracetam (ISF 2522) in patients with organic brain syndrome (a double-blind controlled study with piracetam). Drug Development Research, 2(5), 447–461. https://doi.org/10.1002/ddr.430020506 Notice éditeur · DOI · Wiley
    DOI: 10.1002/ddr.430020506

    Contenus utilisant cette ressource : Oxiracétam

  197. Salamone JD, Correa M. (2012). The mysterious motivational functions of mesolimbic dopamine. Neuron, 76(3), 470–485. PubMed · PMID 23141060
    DOI : 10.1016/j.neuron.2012.10.021

    Contenus utilisant cette ressource : Dopamine et motivation : limites des preuves sur les nootropiques

  198. Volkow ND, et al. (2009). Effects of modafinil on dopamine and dopamine transporters in the male human brain: clinical implications. JAMA, 301(11), 1148–1154. PubMed · PMID 19293415
    DOI: 10.1001/jama.2009.351

    Contenus utilisant cette ressource : modafinil

  199. Wattanathorn, J. et al. (2008). Positive modulation of cognition and mood in the healthy elderly volunteer following the administration of Centella asiatica. Journal of Ethnopharmacology, 116(2), 325–332. PubMed · PMID 18191355
    DOI : 10.1016/j.jep.2007.11.038

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  200. Fan X, et al. (2015). Berberine alleviates ox-LDL induced inflammatory factors by up-regulation of autophagy via AMPK/mTOR signaling pathway. Journal of Translational Medicine, 13, 92. PubMed · PMID 25884210
    DOI: 10.1186/s12967-015-0450-z

    Contenus utilisant cette ressource : Berbérine

  201. Lieu CA, et al. (2010). A water extract of Mucuna pruriens provides long-term amelioration of parkinsonism with reduced risk for dyskinesias. Parkinsonism & Related Disorders, 16(7), 458–465. PubMed · PMID 20570206
    DOI : 10.1016/j.parkreldis.2010.04.015

    Contenus utilisant cette ressource : Mucuna Pruriens

  202. Das YT, et al. (2004). Safety of 5-hydroxy-L-tryptophan. Toxicology Letters, 150(1), 111–122. PubMed · PMID 15068828
    DOI : 10.1016/j.toxlet.2003.12.070

    Contenus utilisant cette ressource : 5-HTP

  203. Puttarak P, et al. (2017). Effects of Centella asiatica (L.) Urb. on cognitive function and mood related outcomes: A Systematic Review and Meta-analysis. Scientific Reports, 7(1), 10646. PubMed · PMID 28878245
    DOI: 10.1038/s41598-017-09823-9

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  204. Beal MF. (2004). Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment. Journal of Bioenergetics and Biomembranes, 36(4), 381–386. PubMed · PMID 15377876
    DOI: 10.1023/B:JOBB.0000041772.74810.92

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : mécanismes et preuves

  205. Zvejniece L, et al. (2011). Investigation into stereoselective pharmacological activity of phenotropil. Basic & Clinical Pharmacology & Toxicology, 109(5), 407–412. PubMed · PMID 21689376
    DOI : 10.1111/j.1742-7843.2011.00742.x

    Contenus utilisant cette ressource : Phénylpiracétam

  206. Gudasheva, T.A. et al. (1997). The major metabolite of dipeptide piracetam analogue GVS-111 in rat brain and its similarity to endogenous neuropeptide cyclo-L-prolylglycine. European Journal of Drug Metabolism and Pharmacokinetics, 22(3), 245–252. PubMed · PMID 9358206
    DOI : 10.1007/BF03189814

    Contenus utilisant cette ressource : noopept

  207. Littarru, G.P., Tiano, L. (2007). Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Molecular Biotechnology, 37(1), 31–37. PubMed · PMID 17914161
    DOI : 10.1007/s12033-007-0052-y

    Contenus utilisant cette ressource : Coenzyme Q10

  208. Manyam BV, et al. (2004). Neuroprotective effects of the antiparkinson drug Mucuna pruriens. Phytotherapy Research, 18(9), 706–12. https://doi.org/10.1002/ptr.1514 PubMed · PMID 15478206
    DOI: 10.1002/ptr.1514

    Contenus utilisant cette ressource : Mucuna Pruriens

  209. Orhan, I.E. (2012). Centella asiatica (L.) Urban: From traditional medicine to modern medicine with neuroprotective potential. Evidence-Based Complementary and Alternative Medicine. PubMed · PMID 22666298
    DOI : 10.1155/2012/946259

    Contenus utilisant cette ressource : Centella asiatica (Gotu Kola)

  210. Stirling Anglian Pharmaceuticals. Acepiro 600 mg effervescent tablets: Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/13849/smpc Stirling Anglian Pharmaceuticals / electronic medicines compendium

    Contenus utilisant cette ressource : NAC (N-Acétyl Cystéine)

  211. Montgomery SA, et al. (2003). Meta-analysis of double blind randomized controlled clinical trials of acetyl-L-carnitine versus placebo in the treatment of mild cognitive impairment and mild Alzheimer's disease. International Clinical Psychopharmacology, 18(2), 61–71. PubMed · PMID 12598816
    DOI : 10.1097/00004850-200303000-00001

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  212. Owen DR, et al. (2016). Phenibut (4-amino-3-phenyl-butyric acid): Availability, prevalence of use, desired effects and acute toxicity. Drug and Alcohol Review, 35(5), 591–596. PubMed · PMID 26693960
    DOI : 10.1111/dar.12356

    Contenus utilisant cette ressource : phénibut

  213. Bkaily G, et al. (2020). Taurine and cardiac disease: State of the art and perspectives. Canadian Journal of Physiology and Pharmacology. PubMed · PMID 31560859
    DOI : 10.1139/cjpp-2019-0313

    Contenus utilisant cette ressource : taureau

  214. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA), et al. (2021). Safety of Eurycoma longifolia (Tongkat Ali) root extract as a novel food pursuant to Regulation (EU) 2015/2283. EFSA Journal, 19(12), e06937. https://doi.org/10.2903/j.efsa.2021.6937 PubMed · PMID 34987621
    DOI: 10.2903/j.efsa.2021.6937

    Contenus utilisant cette ressource : Tongkat Ali Stress et cortisol : mesures humaines et recherche sur les compléments

  215. Grossman R. (2005). The role of dimethylaminoethanol in cosmetic dermatology. American Journal of Clinical Dermatology, 6(1), 39–47. PubMed · PMID 15675889
    DOI : 10.2165/00128071-200506010-00005

    Contenus utilisant cette ressource : DMAE

  216. Giurgea C. (1972). [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology]. Actualités pharmacologiques, 25, 115–56. PubMed · PMID 4541214

    Contenus utilisant cette ressource : Piracétam

  217. Kennedy DO, et al. (2010). Effects of resveratrol on cerebral blood flow variables and cognitive performance in humans: a double-blind, placebo-controlled, crossover investigation. American Journal of Clinical Nutrition, 91(6), 1590–1597. PubMed · PMID 20357044
    DOI: 10.3945/ajcn.2009.28641

    Contenus utilisant cette ressource : resvératrol Vieillissement cérébral : limites des recherches sur les nootropiques

  218. Bannai M, Kawai N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Journal of Pharmacological Sciences, 118(2), 145–148. PubMed · PMID 22293292
    DOI : 10.1254/jphs.11r04fm

    Contenus utilisant cette ressource : Sommeil et nootropiques : études humaines et limites

  219. Battleday RM, Brem AK. (2015). Modafinil for cognitive neuroenhancement in healthy non-sleep-deprived subjects: A systematic review. European Neuropsychopharmacology, 25(11), 1865–1881. PubMed · PMID 26381811
    DOI : 10.1016/j.euroneuro.2015.07.028

    Contenus utilisant cette ressource : modafinil

  220. Mills KF, et al. (2016). Long-term administration of nicotinamide mononucleotide mitigates age-associated physiological decline in mice. Cell Metabolism, 24(6), 795–806. PubMed · PMID 28068222
    DOI : 10.1016/j.cmet.2016.09.013

    Contenus utilisant cette ressource : NMN Mitochondries et énergie cérébrale : mécanismes et preuves Vieillissement cérébral : limites des recherches sur les nootropiques

  221. NIH NCCIH. Melatonin: What You Need To Know. https://www.nccih.nih.gov/health/melatonin-what-you-need-to-know NIH NCCIH

    Contenus utilisant cette ressource : mélatonine

  222. Nakamura K, Tanaka Y. (2001). Antidepressant-like effects of aniracetam in aged rats and its mode of action. Psychopharmacology, 158(2), 205–212. PubMed · PMID 11702095
    DOI : 10.1007/s002130100849

    Contenus utilisant cette ressource : aniracétam

  223. Yin J, et al. (2008). Efficacy of berberine in patients with type 2 diabetes mellitus. Metabolism, 57(5), 712–717. PubMed · PMID 18442638
    DOI : 10.1016/j.metabol.2008.01.013

    Contenus utilisant cette ressource : Berbérine

  224. EFSA NDA Panel. (2017). Safety of pyrroloquinoline quinone disodium salt as a novel food pursuant to Regulation (EC) No 258/97. https://www.efsa.europa.eu/en/efsajournal/pub/5058 European Food Safety Authority

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  225. Nobre AC, et al. (2008). L-Theanine, a natural constituent in tea, and its effect on mental state. Asia Pacific Journal of Clinical Nutrition, 17(S1), 167–168. PubMed · PMID 18296328

    Contenus utilisant cette ressource : L-Théanine

  226. EFSA Panel on Nutrition, Novel Foods and Food Allergens (NDA). (2024). Creatine and improvement in cognitive function: Evaluation of a health claim pursuant to article 13(5) of regulation (EC) No 1924/2006. EFSA Journal, 22(11), e9100. PubMed · PMID 39564533
    DOI: 10.2903/j.efsa.2024.9100

    Contenus utilisant cette ressource : Créatine

  227. Fisher MC, et al. (2001). Inhibitors of choline uptake and metabolism cause developmental abnormalities in neurulating mouse embryos. Teratology, 64(2), 114-22. PubMed · PMID 11460263
    DOI: 10.1002/tera.1053

    Contenus utilisant cette ressource : DMAE

  228. Rawson ES, Venezia AC. (2011). Use of creatine in the elderly and evidence for effects on cognitive function in young and old. Amino Acids, 40(5), 1349–1362. PubMed · PMID 21394604
    DOI : 10.1007/s00726-011-0855-9

    Contenus utilisant cette ressource : Performance cérébrale des sportifs : preuves et limites des compléments

  229. Wang J, et al. (2013). Magnesium L-threonate prevents and restores memory deficits associated with neuropathic pain by inhibition of TNF-α. Pain Physician, 16(5), E563–E575. PubMed · PMID 24077207

    Contenus utilisant cette ressource : Mg L-Thréonate

  230. Cheah KL, Norhayati MN, Husniati Yaacob L, Abdul Rahman R. (2021). Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis. PLOS ONE, 16(9), e0257843. PubMed · PMID 34559859
    DOI: 10.1371/journal.pone.0257843

    Contenus utilisant cette ressource : ashwagandha

  231. Cohen PA, et al. (2022). Levodopa Content of Mucuna pruriens Supplements in the NIH Dietary Supplement Label Database. JAMA Neurology, 79(10), 1085–1086. https://doi.org/10.1001/jamaneurol.2022.2184 PubMed · PMID 35939305
    DOI: 10.1001/jamaneurol.2022.2184

    Contenus utilisant cette ressource : Mucuna Pruriens Dopamine et motivation : limites des preuves sur les nootropiques

  232. Trauner G, et al. (2008). Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta Medica, 74(1), 19–24. PubMed · PMID 18095218
    DOI: 10.1055/s-2007-993761

    Contenus utilisant cette ressource : Valériane (Valeriana)

  233. Shevtsov VA, et al. (2003). A randomized trial of two different doses of a SHR-5 Rhodiola rosea extract versus placebo and control of capacity for mental work. Phytomedicine, 10(2-3), 95–105. PubMed · PMID 12725561
    DOI : 10.1078/094471103321659780

    Contenus utilisant cette ressource : rhodiola rosea

  234. Henkel RR, et al. (2014). Tongkat Ali as a potential herbal supplement for physically active male and female seniors--a pilot study. Phytotherapy Research, 28(4), 544–550. PubMed · PMID 23754792
    DOI: 10.1002/ptr.5017

    Contenus utilisant cette ressource : Tongkat Ali

  235. US Food and Drug Administration. GRN No. 209: L-theanine. https://hfpappexternal.fda.gov/scripts/fdcc/index.cfm?set=GRASNotices&id=209 US Food and Drug Administration

    Contenus utilisant cette ressource : L-Théanine

  236. Huang BM, et al. (2001). Cordyceps sinensis and its fractions stimulate MA-10 mouse Leydig tumor cell steroidogenesis. Journal of Andrology, 22(5), 831–7. PubMed · PMID 11545297

    Contenus utilisant cette ressource : cordyceps

  237. Peth-Nui T, et al. (2012). Effects of 12-week Bacopa monnieri consumption on attention, cognitive processing, working memory, and functions of both cholinergic and monoaminergic systems in healthy elderly volunteers. Evidence-Based Complementary and Alternative Medicine. PubMed · PMID 23320031
    DOI: 10.1155/2012/606424

    Contenus utilisant cette ressource : Bacopa Monnieri

  238. Minzenberg MJ, Carter CS. (2008). Modafinil: a review of neurochemical actions and effects on cognition. Neuropsychopharmacology, 33(7), 1477–1502. PubMed · PMID 17712350
    DOI : 10.1038/sj.npp.1301534

    Contenus utilisant cette ressource : modafinil

  239. Stohs SJ. (2014). Safety and efficacy of shilajit (mumie, moomiyo). Phytotherapy Research, 28(4), 475–479. PubMed · PMID 23733436
    DOI : 10.1002/ptr.5018

    Contenus utilisant cette ressource : shilajit

  240. Szatmari SZ, Whitehouse PJ. (2003). Vinpocetine for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, (1), CD003119. PubMed · PMID 12535455
    DOI: 10.1002/14651858.CD003119

    Contenus utilisant cette ressource : vinpocétine

  241. Witte AV, et al. (2014). Effects of resveratrol on memory performance, hippocampal functional connectivity, and glucose metabolism in healthy older adults. Journal of Neuroscience, 34(23), 7862–7870. PubMed · PMID 24899709
    DOI : 10.1523/JNEUROSCI.0385-14.2014

    Contenus utilisant cette ressource : resvératrol Vieillissement cérébral : limites des recherches sur les nootropiques

  242. Bereczki D & Fekete I (2008). Vinpocetine for acute ischaemic stroke. Cochrane Database of Systematic Reviews, (1), CD000480. PubMed · PMID 18253980
    DOI : 10.1002/14651858.CD000480.pub2

    Contenus utilisant cette ressource : vinpocétine

  243. Hasheminasab FS, Hajimonfarednejad M, Najibi SM, Hashempur MH. (2026). Adverse Events of Saffron (Crocus sativus L.): Systematic Review of Current Evidence. Health Science Reports, 9(5), e72212. PubMed · PMID 42057871
    DOI: 10.1002/hsr2.72212

    Contenus utilisant cette ressource : Extrait de Safran

  244. Langade D, et al. (2019). Efficacy and safety of Ashwagandha (Withania somnifera) root extract in insomnia and anxiety: a double-blind, randomized, placebo-controlled study. Cureus, 11(9), e5797. PubMed · PMID 31728244
    DOI : 10.7759/cureus.5797

    Contenus utilisant cette ressource : ashwagandha

  245. Earnest CP, et al. (2004). Effects of a commercial herbal-based formula on exercise performance in cyclists. Medicine and Science in Sports and Exercise, 36(3), 504–509. PubMed · PMID 15076794
    DOI : 10.1249/01.mss.0000125157.49280.af

    Contenus utilisant cette ressource : cordyceps

  246. Zeng M, et al. (2024). Effects of Ginseng on Cognitive Function: A Systematic Review and Meta-Analysis. Phytotherapy Research, 38(12), 6023–6034. PubMed · PMID 39474788
    DOI: 10.1002/ptr.8359

    Contenus utilisant cette ressource : Panax Ginseng

  247. Lee G, et al. (2021). Association of L-α Glycerylphosphorylcholine With Subsequent Stroke Risk After 10 Years. JAMA Network Open, 4(11), e2136008. https://doi.org/10.1001/jamanetworkopen.2021.36008 PubMed · PMID 34817582
    DOI: 10.1001/jamanetworkopen.2021.36008

    Contenus utilisant cette ressource : Alpha-GPC

  248. Tamakoshi M, et al. (2023). Pyrroloquinoline quinone disodium salt improves brain function in both younger and older adults. Food & function, 14(5), 2496-2501. https://doi.org/10.1039/d2fo01515c PubMed · PMID 36807425
    DOI: 10.1039/d2fo01515c

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  249. Ames BN, et al. (2004). Delaying the mitochondrial decay of aging with acetylcarnitine. Annals of the New York Academy of Sciences, 1033, 108–116. PubMed · PMID 15591008
    DOI: 10.1196/annals.1320.010

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  250. Biswas TK, et al. (2010). Clinical evaluation of spermatogenic activity of processed Shilajit in oligospermia. Andrologia, 42(1), 48–56. PubMed · PMID 20078516
    DOI : 10.1111/j.1439-0272.2009.00956.x

    Contenus utilisant cette ressource : shilajit

  251. Hershman DL, et al. (2013). Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for the prevention of taxane-induced neuropathy in women undergoing adjuvant breast cancer therapy. Journal of Clinical Oncology, 31(20), 2627–33. https://doi.org/10.1200/JCO.2012.44.8738 PubMed · PMID 23733756
    DOI: 10.1200/JCO.2012.44.8738

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  252. Wang R & Tang XC (2005). Neuroprotective effects of huperzine A. A natural cholinesterase inhibitor for the treatment of Alzheimer's disease. Neurosignals, 14(1–2), 71–82. PubMed · PMID 15956816
    DOI: 10.1159/000085387

    Contenus utilisant cette ressource : Huperzine A

  253. Kemény V, et al. (2005). Acute and chronic effects of vinpocetine on cerebral hemodynamics and neuropsychological performance in multi-infarct patients. Journal of Clinical Pharmacology, 45(9), 1048–54. https://doi.org/10.1177/0091270005279363 PubMed · PMID 16100299
    DOI: 10.1177/0091270005279363

    Contenus utilisant cette ressource : vinpocétine

  254. DeKosky ST, et al. (2008). Ginkgo biloba for prevention of dementia: a randomized controlled trial. JAMA, 300(19), 2253–2262. PubMed · PMID 19017911
    DOI : 10.1001/jama.2008.683

    Contenus utilisant cette ressource : Ginkgo Biloba

  255. Cumin R, et al. (1982). Effects of the novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology, 78(2), 104–111. PubMed · PMID 6817363
    DOI : 10.1007/BF00432244

    Contenus utilisant cette ressource : aniracétam

  256. Dinsdale JR, et al. (1983). Pharmacokinetics of 14C CDP-choline. Arzneimittel-Forschung, 33(7A), 1066–1070. PubMed · PMID 6412727

    Contenus utilisant cette ressource : CDP-Choline

  257. Tan MS, et al. (2015). Efficacy and adverse effects of ginkgo biloba for cognitive impairment and dementia: a systematic review and meta-analysis. Journal of Alzheimer's Disease, 43(2), 589–603. PubMed · PMID 25114079
    DOI : 10.3233/JAD-140837

    Contenus utilisant cette ressource : Ginkgo Biloba

  258. Kennedy DO, Scholey AB. (2003). Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacology Biochemistry and Behavior, 75(3), 687–700. PubMed · PMID 12895687
    DOI : 10.1016/s0091-3057(03)00126-6

    Contenus utilisant cette ressource : Panax Ginseng

  259. NIH NCCIH. Valerian: Usefulness and Safety. https://www.nccih.nih.gov/health/valerian NIH NCCIH

    Contenus utilisant cette ressource : Valériane (Valeriana)

  260. Zahniser NR, et al. (1977). Is 2-dimethylaminoethanol (deanol) indeed a precursor of brain acetylcholine? A gas chromatographic evaluation. The Journal of pharmacology and experimental therapeutics, 200(3), 545-59. PubMed · PMID 850128

    Contenus utilisant cette ressource : DMAE

  261. NIH Office of Dietary Supplements. Vitamin B12: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminB12-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Vitamines, minéraux et cerveau : preuves sur les carences et compléments

  262. Valikovics A (2007). Investigation of the effect of vinpocetine on cerebral blood flow and cognitive functions. Ideggyogy Sz, 60(7–8), 301–310. PubMed · PMID 17713111

    Contenus utilisant cette ressource : vinpocétine

  263. Tian Y, et al. (2008). Pharmacokinetics and bioequivalence study of aniracetam after single-dose administration in healthy Chinese male volunteers. Arzneimittelforschung, 58(10), 497–500. https://doi.org/10.1055/s-0031-1296547 PubMed · PMID 19025058
    DOI: 10.1055/s-0031-1296547

    Contenus utilisant cette ressource : aniracétam

  264. Amsterdam, J.D. et al. (2009). A randomized, double-blind, placebo-controlled trial of oral Matricaria recutita (chamomile) extract therapy for generalized anxiety disorder. Journal of Clinical Psychopharmacology, 29(4), 378–382. PubMed · PMID 19593179
    DOI : 10.1097/JCP.0b013e3181ac935c

    Contenus utilisant cette ressource : Apigénine

  265. Pelsman, A. et al. (2003). GVS-111 prevents oxidative damage and apoptosis in normal and Down's syndrome human cortical neurons. International Journal of Developmental Neuroscience, 21(3), 117–124. PubMed · PMID 12711349
    DOI : 10.1016/s0736-5748(03)00031-5

    Contenus utilisant cette ressource : noopept

  266. Starks MA, et al. (2008). The effects of phosphatidylserine on endocrine response to moderate intensity exercise. Journal of the International Society of Sports Nutrition, 5, 11. PubMed · PMID 18662395
    DOI : 10.1186/1550-2783-5-11

    Contenus utilisant cette ressource : Phosphatidylsérine

  267. Müller WE. (2003). Current St. John's Wort research from mode of action to clinical efficacy. Pharmacological Research, 47(2), 101–109. PubMed · PMID 12543057
    DOI: 10.1016/s1043-6618(02)00266-9

    Contenus utilisant cette ressource : Millepertuis

  268. Babb SM, et al. (2002). Chronic citicoline increases phosphodiesters in the brains of healthy older subjects: an in vivo phosphorus magnetic resonance spectroscopy study. Psychopharmacology, 161(3), 248–254. PubMed · PMID 12021827
    DOI: 10.1007/s00213-002-1045-y

    Contenus utilisant cette ressource : Monophosphate d'uridine

  269. Jakaria M, et al. (2019). Taurine and its analogs in neurological disorders: Focus on therapeutic potential and molecular mechanisms. Redox Biology, 24, 101223. PubMed · PMID 31141786
    DOI : 10.1016/j.redox.2019.101223

    Contenus utilisant cette ressource : taureau

  270. Ziegenfuss T, Landis J, Hofheins J. (2008). Acute supplementation with alpha-glycerylphosphorylcholine augments growth hormone response to, and peak force production during, resistance exercise. Journal of the International Society of Sports Nutrition, 5(Suppl 1), P15. https://doi.org/10.1186/1550-2783-5-S1-P15 Poster de conférence · Springer Nature
    DOI: 10.1186/1550-2783-5-S1-P15

    Contenus utilisant cette ressource : Alpha-GPC

  271. De Jesus Moreno Moreno M. (2003). Cognitive improvement in mild to moderate Alzheimer's dementia after treatment with the acetylcholine precursor choline alfoscerate: a multicenter, double-blind, randomized, placebo-controlled trial. Clinical Therapeutics, 25(1), 178–193. PubMed · PMID 12637119
    DOI : 10.1016/s0149-2918(03)90023-3

    Contenus utilisant cette ressource : Alpha-GPC

  272. Ostrovskaya RU, et al. (2014). Neuroprotective effect of novel cognitive enhancer noopept on AD-related cellular model involves the attenuation of apoptosis and tau hyperphosphorylation. Journal of Biomedical Science, 21(1), 74. PubMed · PMID 25096780
    DOI: 10.1186/s12929-014-0074-2

    Contenus utilisant cette ressource : noopept

  273. Baltic S, et al. (2024). The impact of six-week dihydrogen-pyrroloquinoline quinone supplementation on mitochondrial biomarkers, brain metabolism, and cognition in elderly individuals with mild cognitive impairment: a randomized controlled trial. The journal of nutrition, health & aging, 28(8), 100287. https://doi.org/10.1016/j.jnha.2024.100287 PubMed · PMID 38908296
    DOI: 10.1016/j.jnha.2024.100287

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  274. Scholey A, et al. (2014). Anti-stress effects of lemon balm-containing foods. Nutrients, 6(11), 4805–4821. PubMed · PMID 25360512
    DOI : 10.3390/nu6114805

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  275. Lapin I. (2001). Phenibut (beta-phenyl-GABA): a tranquilizer and nootropic drug. CNS Drug Reviews, 7(4), 471–481. PubMed · PMID 11830761
    DOI : 10.1111/j.1527-3458.2001.tb00211.x

    Contenus utilisant cette ressource : phénibut

  276. World Health Organization Expert Committee on Drug Dependence. (2021). Phenibut: Critical Review Report (advance copy), section 4B. https://cdn.who.int/media/docs/default-source/essential-medicines/unedited--advance-copy-44th-ecdd-critical-review-report_phenibut.pdf World Health Organization · Expert Committee on Drug Dependence

    Contenus utilisant cette ressource : phénibut

  277. Chandrasekhar K, et al. (2012). A prospective, randomized double-blind, placebo-controlled study of safety and efficacy of a high-concentration full-spectrum extract of ashwagandha root in reducing stress and anxiety in adults. Indian Journal of Psychological Medicine, 34(3), 255–262. PubMed · PMID 23439798
    DOI : 10.4103/0253-7176.106022

    Contenus utilisant cette ressource : Stress et cortisol : mesures humaines et recherche sur les compléments

  278. Winblad, B. (2005). Piracetam: A review of pharmacological properties and clinical uses. CNS Drug Reviews, 11(2), 169–182. PubMed · PMID 16007238
    DOI : 10.1111/j.1527-3458.2005.tb00268.x

    Contenus utilisant cette ressource : Piracétam

  279. Stough C, et al. (2001). The chronic effects of an extract of Bacopa monniera on cognitive function in healthy human subjects. Psychopharmacology, 156(4), 481–484. PubMed · PMID 11498727
    DOI : 10.1007/s002130100815

    Contenus utilisant cette ressource : Stacks nootropiques : preuves et risques de cinq associations

  280. Hamzah S, Yusof A. (2003). The ergogenic effects of Eurycoma longifolia Jack: A pilot study. British Journal of Sports Medicine, 37(5), 465–466. https://bjsm.bmj.com/content/37/5/464 Résumé de conférence · BMJ

    Contenus utilisant cette ressource : Tongkat Ali

  281. van Wegberg AMJ, et al. (2017). The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet Journal of Rare Diseases, 12(1), 162. https://doi.org/10.1186/s13023-017-0685-2 PubMed · PMID 29025426
    DOI: 10.1186/s13023-017-0685-2

    Contenus utilisant cette ressource : L-Tyrosine

  282. Swardfager W, et al. (2013). Potential roles of zinc in the pathophysiology and treatment of major depressive disorder. Neuroscience and Biobehavioral Reviews, 37(5), 911–929. PubMed · PMID 23567517
    DOI : 10.1016/j.neubiorev.2013.03.018

    Contenus utilisant cette ressource : Vitamines, minéraux et cerveau : preuves sur les carences et compléments

  283. Shuid AN, et al. (2011). The anti-osteoporotic effect of Eurycoma Longifolia in aged orchidectomised rat model. Aging Male, 14(3), 150–4. https://doi.org/10.3109/13685538.2010.511327 PubMed · PMID 20874437
    DOI: 10.3109/13685538.2010.511327

    Contenus utilisant cette ressource : Tongkat Ali

  284. Bliss TV, Collingridge GL. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature, 361, 31–39. PubMed · PMID 8421494
    DOI: 10.1038/361031a0

    Contenus utilisant cette ressource : Neuroplasticité : mécanismes, données humaines et limites de la recherche

  285. NIH Office of Dietary Supplements. Dietary Supplements for Exercise and Athletic Performance: Health Professional Fact Sheet. https://ods.od.nih.gov/factsheets/ExerciseAndAthleticPerformance-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Créatine

  286. National Center for Complementary and Integrative Health. Rhodiola: Usefulness and Safety. https://www.nccih.nih.gov/health/rhodiola NIH NCCIH

    Contenus utilisant cette ressource : rhodiola rosea

  287. Tiev KP, et al. (1999). Treatment of chronic postinfectious fatigue: randomized double-blind study of two doses of sulbutiamine (400–600 mg/day) versus placebo. La Revue de médecine interne, 20(10), 912–918. PubMed · PMID 10573727
    DOI : 10.1016/s0248-8663(00)80096-x

    Contenus utilisant cette ressource : Sulbutiamine

  288. Bent S, et al. (2006). Valerian for sleep: a systematic review and meta-analysis. American Journal of Medicine, 119(12), 1005–1012. PubMed · PMID 17145239
    DOI: 10.1016/j.amjmed.2006.02.026

    Contenus utilisant cette ressource : Valériane (Valeriana)

  289. Lim JS, et al. (2026). Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial. European Stroke Journal, 11(1), 23969873251350141. https://doi.org/10.1093/esj/23969873251350141 PubMed · PMID 41614470
    DOI: 10.1093/esj/23969873251350141

    Contenus utilisant cette ressource : Oxiracétam

  290. Herxheimer A, Petrie KJ. (2002). Melatonin for the prevention and treatment of jet lag. Cochrane Database of Systematic Reviews, (2), CD001520. PubMed · PMID 12076414
    DOI: 10.1002/14651858.CD001520

    Contenus utilisant cette ressource : mélatonine

  291. Fernández-San-Martín MI, et al. (2010). Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine, 11(6), 505–511. PubMed · PMID 20347389
    DOI: 10.1016/j.sleep.2009.12.009

    Contenus utilisant cette ressource : Valériane (Valeriana)

  292. Spasov AA, et al. (2000). A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine, 7(2), 85–89. PubMed · PMID 10839209
    DOI : 10.1016/S0944-7113(00)80078-1

    Contenus utilisant cette ressource : rhodiola rosea Performance cérébrale des sportifs : preuves et limites des compléments

  293. Punja S, Shamseer L, Olson K, Vohra S. (2014). Rhodiola Rosea for Mental and Physical Fatigue in Nursing Students: A Randomized Controlled Trial. PLoS ONE, 9(9), e108416. PubMed · PMID 25268730
    DOI: 10.1371/journal.pone.0108416

    Contenus utilisant cette ressource : rhodiola rosea

  294. Nakamura K, et al. (2001). Anxiolytic effects of aniracetam in three different mouse models of anxiety and the underlying mechanism. European Journal of Pharmacology, 420(1), 33–43. https://doi.org/10.1016/s0014-2999(01)01005-6 PubMed · PMID 11412837
    DOI: 10.1016/s0014-2999(01)01005-6

    Contenus utilisant cette ressource : aniracétam

  295. Medicines and Healthcare products Regulatory Agency. (2020). Modafinil (Provigil): increased risk of congenital malformations if used during pregnancy. https://www.gov.uk/drug-safety-update/modafinil-provigil-increased-risk-of-congenital-malformations-if-used-during-pregnancy Medicines and Healthcare products Regulatory Agency

    Contenus utilisant cette ressource : modafinil

  296. van der Pijl PC, Chen L, Mulder TPJ. (2010). Human disposition of L-theanine in tea or aqueous solution. Journal of Functional Foods, 2(4), 239–244. https://doi.org/10.1016/j.jff.2010.08.001 Notice éditeur · DOI · Elsevier
    DOI: 10.1016/j.jff.2010.08.001

    Contenus utilisant cette ressource : L-Théanine

  297. Owen, G.N. et al. (2008). The combined effects of L-Theanine and caffeine on cognitive performance and mood. Nutritional Neuroscience, 11(4), 193–198. PubMed · PMID 18681988
    DOI : 10.1179/147683008X301513

    Contenus utilisant cette ressource : Caféine et L-théanine : études sur l’attention et limites

  298. Crook TH, et al. (1991). Effects of phosphatidylserine in age-associated memory impairment. Neurology, 41(5), 644–649. PubMed · PMID 2027477
    DOI : 10.1212/wnl.41.5.644

    Contenus utilisant cette ressource : Phosphatidylsérine

  299. Benton D & Donohoe R (2011). The influence of creatine supplementation on the cognitive functioning of vegetarians and omnivores. British Journal of Nutrition, 105(7), 1100–1105. PubMed · PMID 21118604
    DOI : 10.1017/S0007114510004733

    Contenus utilisant cette ressource : Créatine

  300. Fisman M, et al. (1981). Double-blind trial of 2-dimethylaminoethanol in Alzheimer's disease. The American Journal of Psychiatry, 138(7), 970–972. PubMed · PMID 7020434
    DOI : 10.1176/ajp.138.7.970

    Contenus utilisant cette ressource : DMAE

  301. Ishaque S, et al. (2012). Rhodiola rosea for physical and mental fatigue: a systematic review. BMC Complementary and Alternative Medicine, 12, 70. PubMed · PMID 22643043
    DOI : 10.1186/1472-6882-12-70

    Contenus utilisant cette ressource : rhodiola rosea

  302. Wang M, Cao N, Shou Z, Pan J. (2026). Efficacy and safety of oxiracetam for cognitive and functional outcomes after acute traumatic brain injury in Chinese populations: a systematic review and meta-analysis of randomized controlled trials. Frontiers in Pharmacology, 17, 1894256. https://doi.org/10.3389/fphar.2026.1894256 PubMed · PMID 42835276
    DOI: 10.3389/fphar.2026.1894256

    Contenus utilisant cette ressource : Oxiracétam

  303. Agha-Hosseini M, et al. (2008). Crocus sativus L. (saffron) in the treatment of premenstrual syndrome: a double-blind, randomised and placebo-controlled trial. BJOG, 115(4), 515–9. https://doi.org/10.1111/j.1471-0528.2007.01652.x PubMed · PMID 18271889
    DOI: 10.1111/j.1471-0528.2007.01652.x

    Contenus utilisant cette ressource : Extrait de Safran

  304. Hershman DL, et al. (2018). Two-Year Trends of Taxane-Induced Neuropathy in Women Enrolled in a Randomized Trial of Acetyl-L-Carnitine (SWOG S0715). Journal of the National Cancer Institute, 110(6), 669–676. https://doi.org/10.1093/jnci/djx259 PubMed · PMID 29361042
    DOI: 10.1093/jnci/djx259

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  305. Secades JJ. (2011). Citicoline: pharmacological and clinical review, 2010 update. Revista de Neurología, 52(Suppl 2), S1–S62. PubMed · PMID 21432836

    Contenus utilisant cette ressource : CDP-Choline

  306. Medsafe. (2018). Beware turmeric/curcumin containing products can interact with warfarin. https://medsafe.govt.nz/safety/ews/2018/Turmeric.asp Medsafe

    Contenus utilisant cette ressource : curcumine

  307. Akhondzadeh S, et al. (2004). Comparison of Crocus sativus L. and imipramine in the treatment of mild to moderate depression: a pilot double-blind randomized trial. BMC Complementary and Alternative Medicine, 4, 12. PubMed · PMID 15341662
    DOI: 10.1186/1472-6882-4-12

    Contenus utilisant cette ressource : Extrait de Safran

  308. Weinmann S, et al. (2010). Effects of Ginkgo biloba in dementia: systematic review and meta-analysis. BMC Geriatrics, 10, 14. PubMed · PMID 20236541
    DOI: 10.1186/1471-2318-10-14

    Contenus utilisant cette ressource : Ginkgo Biloba

  309. Jongkees BJ, et al. (2015). Effect of tyrosine supplementation on clinical and healthy populations under stress or cognitive demands. Journal of Psychiatric Research, 70, 50–57. PubMed · PMID 26424423
    DOI: 10.1016/j.jpsychires.2015.08.014

    Contenus utilisant cette ressource : Dopamine et motivation : limites des preuves sur les nootropiques

  310. Ito I, et al. (1990). Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam. Journal of Physiology, 424, 533–543. PubMed · PMID 1975272
    DOI : 10.1113/jphysiol.1990.sp018081

    Contenus utilisant cette ressource : aniracétam

  311. Shoba G, et al. (1998). Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers. Planta Medica, 64(4), 353–356. PubMed · PMID 9619120
    DOI : 10.1055/s-2006-957450

    Contenus utilisant cette ressource : curcumine

  312. Rafii MS, et al. (2011). A phase II trial of huperzine A in mild to moderate Alzheimer disease. Neurology, 76(16), 1389–1394. https://doi.org/10.1212/WNL.0b013e318216eb7b PubMed · PMID 21502597
    DOI: 10.1212/WNL.0b013e318216eb7b

    Contenus utilisant cette ressource : Huperzine A

  313. Su KP, et al. (2003). Omega-3 fatty acids in major depressive disorder: a preliminary double-blind, placebo-controlled trial. European Neuropsychopharmacology, 13(4), 267–271. PubMed · PMID 12888186
    DOI : 10.1016/s0924-977x(03)00032-4

    Contenus utilisant cette ressource : Omega-3 DHA/EPA

  314. US Food and Drug Administration. Spilling the Beans: How Much Caffeine is Too Much? https://www.fda.gov/consumers/consumer-updates/spilling-beans-how-much-caffeine-too-much US Food and Drug Administration

    Contenus utilisant cette ressource : Cycles de nootropiques : preuves et limites

  315. Wieland LS, et al. (2026). Ginkgo biloba for cognitive impairment and dementia. Cochrane Database of Systematic Reviews, Issue 2, CD013661. PubMed · PMID 41641880
    DOI: 10.1002/14651858.CD013661.pub2

    Contenus utilisant cette ressource : Ginkgo Biloba

  316. Linde K, et al. (2008). St John's Wort for major depression. Cochrane Database of Systematic Reviews, (4). PubMed · PMID 18843608
    DOI: 10.1002/14651858.CD000448.pub3

    Contenus utilisant cette ressource : Dépression et anxiété : preuves et risques des compléments naturels

  317. Yang W, et al. (2026). Safety and Metabolism-Related Outcomes of Oral Nicotinamide Mononucleotide Supplementation in Adults: A Systematic Review and Meta-Analysis. Nutrients, 18(14), 2251. https://doi.org/10.3390/nu18142251 PubMed · PMID 42514320
    DOI: 10.3390/nu18142251

    Contenus utilisant cette ressource : NMN

  318. Elston TW, et al. (2014). Aniracetam does not alter cognitive and affective behavior in adult C57BL/6J mice. PLoS One, 9(8), e104443. https://doi.org/10.1371/journal.pone.0104443 PubMed · PMID 25099639
    DOI: 10.1371/journal.pone.0104443

    Contenus utilisant cette ressource : aniracétam

  319. Docherty S, Doughty FL, Smith EF. (2023). The Acute and Chronic Effects of Lion's Mane Mushroom Supplementation on Cognitive Function, Stress and Mood in Young Adults: A Double-Blind, Parallel Groups, Pilot Study. Nutrients, 15(22), 4842. PubMed · PMID 38004235
    DOI: 10.3390/nu15224842

    Contenus utilisant cette ressource : Crinière de Lion

  320. Auteri A, et al. (1992). Pharmacokinetics of pramiracetam in healthy volunteers after oral administration. International Journal of Clinical Pharmacology Research, 12(3), 129–32. PubMed · PMID 1473879

    Contenus utilisant cette ressource : pramiracétam

  321. National Center for Complementary and Integrative Health. Asian Ginseng: Usefulness and Safety. https://www.nccih.nih.gov/health/asian-ginseng NIH NCCIH

    Contenus utilisant cette ressource : Panax Ginseng

  322. Lopresti AL, Smith SJ. (2026). The effects of magnesium L-threonate (Magtein®) on cognitive performance and sleep quality in adults: a randomised, double-blind, placebo-controlled trial. Frontiers in Nutrition, 12, 1729164. https://doi.org/10.3389/fnut.2025.1729164 PubMed · PMID 41601871
    DOI: 10.3389/fnut.2025.1729164

    Contenus utilisant cette ressource : Mg L-Thréonate

  323. Hatton MN, et al. (2018). Excessive postextraction bleeding associated with Cordyceps sinensis: a case report and review of select traditional medicines used by Vietnamese people living in the United States. Oral surgery, oral medicine, oral pathology and oral radiology, 126(6), 494-500. PubMed · PMID 30195658
    DOI: 10.1016/j.oooo.2018.07.005

    Contenus utilisant cette ressource : cordyceps

  324. NIH National Center for Complementary and Integrative Health. Ashwagandha: Usefulness and Safety. https://www.nccih.nih.gov/health/ashwagandha NIH NCCIH

    Contenus utilisant cette ressource : ashwagandha Stress et cortisol : mesures humaines et recherche sur les compléments

  325. Magnussen I, Engbaek F. (1978). The effects of aromatic amino acid decarboxylase inhibitors on plasma concentrations of 5-hydroxytryptophan in man. Acta Pharmacologica et Toxicologica, 43(1), 36–42. PubMed · PMID 309271
    DOI: 10.1111/j.1600-0773.1978.tb02229.x

    Contenus utilisant cette ressource : 5-HTP

  326. Noguchi-Shinohara M, et al. (2020). Safety and efficacy of Melissa officinalis extract containing rosmarinic acid in the prevention of Alzheimer's disease progression. Scientific Reports, 10(1), 18627. doi:10.1038/s41598-020-73729-2. PubMed · PMID 33122694
    DOI: 10.1038/s41598-020-73729-2

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  327. Shaw K, Turner J, Del Mar C. (2002). Tryptophan and 5-hydroxytryptophan for depression. Cochrane Database of Systematic Reviews, (1), CD003198. PubMed · PMID 11869656
    DOI: 10.1002/14651858.CD003198

    Contenus utilisant cette ressource : 5-HTP

  328. Netherlands National Institute for Public Health and the Environment (RIVM). (2024). Risk assessment of herbal preparations containing seed extracts of Mucuna pruriens. Report 2024-0087. https://www.rivm.nl/publicaties/risk-assessment-of-herbal-preparations-containing-seed-extracts-of-mucuna-pruriens Netherlands National Institute for Public Health and the Environment (RIVM)

    Contenus utilisant cette ressource : Mucuna Pruriens

  329. Nakano M, Yamamoto T, Okamura H, Tsuda A, Kowatari Y. (2012). Effects of Oral Supplementation with Pyrroloquinoline Quinone on Stress, Fatigue, and Sleep. Functional Foods in Health and Disease, 2(8), 307–324. https://doi.org/10.31989/ffhd.v2i8.81 Notice éditeur · DOI · Functional Food Center
    DOI: 10.31989/ffhd.v2i8.81

    Contenus utilisant cette ressource : PQQ (Pyrroloquinoline Quinone)

  330. Kennedy DO, et al. (2002). Modulation of mood and cognitive performance following acute administration of Melissa officinalis (lemon balm). Pharmacology Biochemistry and Behavior, 72(4), 953–964. PubMed · PMID 12062586
    DOI: 10.1016/s0091-3057(02)00777-3

    Contenus utilisant cette ressource : Mélisse (Mélisse citronnelle)

  331. Pratte MA, et al. (2014). An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withania somnifera). Journal of Alternative and Complementary Medicine, 20(12), 901–908. PubMed · PMID 25405876
    DOI : 10.1089/acm.2014.0177

    Contenus utilisant cette ressource : ashwagandha

  332. Walle T, et al. (2004). High absorption but very low bioavailability of oral resveratrol in humans. Drug metabolism and disposition: the biological fate of chemicals, 32(12), 1377-82. https://doi.org/10.1124/dmd.104.000885 PubMed · PMID 15333514
    DOI: 10.1124/dmd.104.000885

    Contenus utilisant cette ressource : resvératrol

  333. Raut AA, et al. (2012). Exploratory study to evaluate tolerability, safety, and activity of Ashwagandha (Withania somnifera) in healthy volunteers. Journal of Ayurveda and Integrative Medicine, 3(3), 111–114. PubMed · PMID 23125505
    DOI : 10.4103/0975-9476.100168

    Contenus utilisant cette ressource : ashwagandha

  334. Bianchetti A, et al. (2003). Effects of acetyl-L-carnitine in Alzheimer's disease patients unresponsive to acetylcholinesterase inhibitors. Current Medical Research and Opinion, 19(4), 350–353. PubMed · PMID 12841930
    DOI : 10.1185/030079903125001776

    Contenus utilisant cette ressource : Acétyl-L-Carnitine

  335. Anderson GD, et al. (2005). Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytotherapy Research, 19(9), 801–803. PubMed · PMID 16220575
    DOI: 10.1002/ptr.1742

    Contenus utilisant cette ressource : Valériane (Valeriana)

  336. Shurtleff D, et al. (1994). Tyrosine reverses a cold-induced working memory deficit in humans. Pharmacology Biochemistry and Behavior, 47(4), 935–941. PubMed · PMID 8029265
    DOI : 10.1016/0091-3057(94)90299-2

    Contenus utilisant cette ressource : L-Tyrosine

  337. Chowanadisai W, et al. (2010). Pyrroloquinoline quinone stimulates mitochondrial biogenesis through cAMP response element-binding protein phosphorylation and increased PGC-1alpha expression. The Journal of biological chemistry, 285(1), 142-52. PubMed · PMID 19861415
    DOI: 10.1074/jbc.M109.030130

    Contenus utilisant cette ressource : Mitochondries et énergie cérébrale : mécanismes et preuves

  338. Neznamov, G.G. & Teleshova, E.S. (2009). Comparative studies of Noopept and piracetam in the treatment of patients with mild cognitive disorders in organic brain diseases of vascular and traumatic origin. Neuroscience and Behavioral Physiology, 39(3), 311–321. PubMed · PMID 19234797
    DOI : 10.1007/s11055-009-9128-4

    Contenus utilisant cette ressource : noopept

  339. Olsson EM, et al. (2009). A randomised, double-blind, placebo-controlled, parallel-group study of the standardised extract shr-5 of the roots of Rhodiola rosea in the treatment of subjects with stress-related fatigue. Planta Medica, 75(2), 105–112. PubMed · PMID 19016404
    DOI: 10.1055/s-0028-1088346

    Contenus utilisant cette ressource : Dopamine et motivation : limites des preuves sur les nootropiques

  340. Sanmukhani J, et al. (2014). Efficacy and safety of curcumin in major depressive disorder: a randomized controlled trial. Phytotherapy Research, 28(4), 579–585. PubMed · PMID 23832433
    DOI : 10.1002/ptr.5025

    Contenus utilisant cette ressource : curcumine

  341. Fredholm, B.B. et al. (1999). Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacological Reviews, 51(1), 83–133. PubMed · PMID 10049999

    Contenus utilisant cette ressource : Cycles de nootropiques : preuves et limites

  342. Xu SS, et al. (1995). Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao, 16(5), 391–395. PubMed · PMID 8701750

    Contenus utilisant cette ressource : Huperzine A

  343. Neri DF, et al. (1995). The effects of tyrosine on cognitive performance during extended wakefulness. Aviation, Space, and Environmental Medicine, 66(4), 313–319. PubMed · PMID 7794222

    Contenus utilisant cette ressource : N-Acétyl L-Tyrosine L-Tyrosine

  344. Xu C, Bi S, Zhang W, Luo L. (2024). The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, 11, 1424972. PubMed · PMID 39070254
    DOI: 10.3389/fnut.2024.1424972

    Contenus utilisant cette ressource : Créatine

  345. US Food and Drug Administration. Vinpocetine in Dietary Supplements. https://www.fda.gov/food/information-select-dietary-supplement-ingredients-and-other-substances/vinpocetine-dietary-supplements US Food and Drug Administration

    Contenus utilisant cette ressource : vinpocétine

  346. Brzezinski A, et al. (2005). Effects of exogenous melatonin on sleep: a meta-analysis. Sleep Medicine Reviews, 9(1), 41–50. PubMed · PMID 15649737
    DOI: 10.1016/j.smrv.2004.06.004

    Contenus utilisant cette ressource : mélatonine Sommeil et nootropiques : études humaines et limites

  347. Kimura K, et al. (2007). L-Theanine reduces psychological and physiological stress responses. Biological Psychology, 74(1), 39–45. PubMed · PMID 16930802
    DOI : 10.1016/j.biopsycho.2006.06.006

    Contenus utilisant cette ressource : L-Théanine

  348. Chow HH, et al. (2010). Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study. Cancer Prevention Research (Philadelphia, PA), 3(9), 1168-75. https://doi.org/10.1158/1940-6207.CAPR-09-0155 PubMed · PMID 20716633
    DOI: 10.1158/1940-6207.CAPR-09-0155

    Contenus utilisant cette ressource : resvératrol

  349. Singh P, et al. (2023). Taurine deficiency as a driver of aging. Science, 380(6649), eabn9257. PubMed · PMID 37289866
    DOI : 10.1126/science.abn9257

    Contenus utilisant cette ressource : taureau

  350. Netherlands National Institute for Public Health and the Environment (RIVM). (2024). Risk assessment of herbal preparations containing Huperzia serrata. https://www.rivm.nl/publicaties/risk-assessment-of-herbal-preparations-containing-huperzia-serrata Netherlands National Institute for Public Health and the Environment (RIVM)

    Contenus utilisant cette ressource : Huperzine A

  351. NIH National Center for Complementary and Integrative Health. Coenzyme Q10. https://www.nccih.nih.gov/health/coenzyme-q10 NIH NCCIH

    Contenus utilisant cette ressource : Coenzyme Q10

  352. Ricci, S. et al. (2012). Piracetam for acute ischaemic stroke. Cochrane Database of Systematic Reviews, Issue 9. PubMed · PMID 22972044
    DOI : 10.1002/14651858.CD000419.pub3

    Contenus utilisant cette ressource : Piracétam

  353. Ritsner MS, et al. (2011). L-theanine relieves positive, activation, and anxiety symptoms in patients with schizophrenia and schizoaffective disorder: an 8-week, randomized, double-blind, placebo-controlled, 2-center study. Journal of Clinical Psychiatry, 72(1), 34–42. PubMed · PMID 21208586
    DOI: 10.4088/JCP.09m05324gre

    Contenus utilisant cette ressource : L-Théanine

  354. Panossian A, Wikman G. (2010). Effects of Adaptogens on the Central Nervous System and the Molecular Mechanisms Associated with Their Stress-Protective Activity. Pharmaceuticals, 3(1), 188–224. PubMed · PMID 27713248
    DOI : 10.3390/ph3010188

    Contenus utilisant cette ressource : rhodiola rosea

  355. NIH Office of Dietary Supplements. Vitamin K: Fact Sheet for Health Professionals. https://ods.od.nih.gov/factsheets/VitaminK-HealthProfessional/ NIH Office of Dietary Supplements

    Contenus utilisant cette ressource : Vitamine D3

  356. Xu C, Bi S, Zhang W, Luo L. (2025). Corrigendum: The effects of creatine supplementation on cognitive function in adults: a systematic review and meta-analysis. Frontiers in Nutrition, 12, 1570800. https://www.frontiersin.org/journals/nutrition/articles/10.3389/fnut.2025.1570800/full Notice éditeur · DOI · Frontiers in Nutrition
    DOI: 10.3389/fnut.2025.1570800

    Contenus utilisant cette ressource : Créatine

  357. Holick MF. (2007). Vitamin D deficiency. New England Journal of Medicine, 357(3), 266–281. PubMed · PMID 17634462
    DOI: 10.1056/NEJMra070553

    Contenus utilisant cette ressource : Vitamine D3 Vitamines, minéraux et cerveau : preuves sur les carences et compléments